History of the World Allergy Organization: The First 50 Years of IAA/IAACI/WAO by Alain L. de Weck
NOTES OF ALLERGY WATCHERS
History of theWorld AllergyOrganization: The First 50 Years
of IAA/IAACI/WAO
Alain L. de Weck, MD
Key Words: World Allergy Organization, International Association
of Allergology, International Association of Allergology and Clini-
cal Immunology, international allergy congresses
(WAO Journal 2011; 4:193–230)
History of the World Allergy Organization: In 1951, the
leaders in allergy from all over the world came to-
gether to form the International Association of Aller-
gology and Clinical Immunology (IAACI). For the next
60 years, the allergy world converged at the IAACI
triennial meetings, which became biennial in 2003.
The international meetings, originally named the Inter-
national Congress of Allergology and Clinical Immu-
nology (ICACI), are now the World Allergy Congress
(WAC) hosted by the World Allergy Organization
(WAO). Everyone who has aspired to have worldwide
recognition has played a part in IAACI-WAO. The His-
tory of the World Allergy Organization traces the
global arc of the allergy ﬁeld over the past 60 years.
The current ofﬁcers of WAO elected to focus on this rich
history, inviting prominent leaders who are interested in
being part of this history project to write about their time
with IAACI-WAO. This series will be presented in Can-
cún, México as part of the XXII World Allergy Congress
(December 4-8, 2011). Leading up to the Congress in
Cancún, the World Allergy Organization Journal is pre-
senting segments of the History as part of the “Notes of
Allergy Watchers Series.” Please enjoy.
dMichael A. Kaliner, MD
Historian and Past President (2006–2007)
World Allergy Organization
This is the ﬁrst comprehensive attempt to report variousaspects of the history of the International Association of
Allergology and Clinical Immunology (IAACI) during its ﬁrst
50 years of existence (1951–2000), later to become the World
Allergy Organization (WAO). It is based on historical docu-
ments available on the Internet but mostly on my personal
archives collected during 30 years (!) of ofﬁce at the Executive
Committee level (1970–2000). For the earlier period of 20 years,
however, several gaps in the documentation seem to exist.
HISTORICAL DEVELOPMENT OF ALLERGY AND
THE ALLERGOLOGY SPECIALTYdSUMMARY
OF IAACI HISTORY (1951–2000)
The early history of the International Association of
Allergology (IAA), later the IAACI, is somewhat difﬁcult to
reconstitute because few publications or written reports on
IAACI activities in the early years seem to remain. From
1951 to 1967, the secretariat and the archives of the IAA
obviously remained in the hands of individual “amateurs,”
particularly the presidents and secretaries-general, who did
not institute central archives but kept IAA papers within their
personal documents. Some may have saved such personal
papers but in various places, and they have not been accessi-
ble to me, the more as most of the protagonists have died.
My personal acquaintance with the IAA starts with the
V International Congress of Allergology and Clinical Immu-
nology in Madrid in 1964, which I attended at the age of 36.
In contrast with the beliefs of some who have seen me
associated so long with the IAACI, I have not been a “founder
member”: for this, I should be by now almost 100!! Since
1970, I have kept many documents and meeting reports from
various IAA committees and congresses. It is on that basis that
these historical reminiscences have been written. The original
documents are by now collected in central archives at the
WAO secretariat located in the United States in Milwaukee.
The history of allergy as a medical and scientiﬁc
discipline has been the subject of numerous reviews and books
(Walter and Holtzman,1 Merikas et al,2 and Bungy et al3). If the
real birth of allergy as medically recognized phenomena and
diseases dates from the end of the 19th century and the begin-
ning of the 20th century (eg, Blackley: allergy to pollen, 1873;
Portier and Richet: discovery of anaphylaxis, 1902; von Pirquet:
deﬁnition of allergy, 1905; Noon: immunotherapy, 1911), few
physicians devoted themselves fully to research, diagnosis, and
treatment of allergic diseases until World War II. Accordingly,
few national or regional groups in allergology were founded
before 1945. By 1950, however, particularly under the impulse
of active North Americans and British, French, and South
American physicians and biologists devoted to allergology, the
climate seemed ripe for the creation not only of national socie-
ties but also of a professional society at the international level.
This became the original IAA, ofﬁcially founded in Zürich in
1951. This is usually given as the ofﬁcial birth date of the \IAA,
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but an editorial by Fred W. Wittich, the ﬁrst president of the
IAA, in the ﬁrst issue of the International Archives of Allergy
and Applied Immunology in 1950, revealed that the IAA was
actually ﬁrst incorporated in the United States in August 1945.4
This current review is limited to the ﬁrst 50 years of the
association. This is almost a natural partition. On the one
hand, I have been personally involved with the association at
the Executive Committee level from 1970 to 2000, 30 years,
which is certainly unprecedented, resented by some as an
example of an old crocodile’s survival but which certainly
gives me a real historical perspective on the development of
professional allergy in the second half of the 20th century on
a world scale. It also makes it a duty, for historical purposes,
to write down the record, even if possibly biased by personal
prejudice. In my eyes, the IAA has gone through several
distinct periodsddistinct on the one hand through the rapid
evolution of allergology and immunology and on the other
hand under the impulse of some of its presidents.
1951 to 1965: Toward an International
Clinical and Scientific Association
Around the end of World War II, under the impulse
primarily of physicians such as Robert Cooke, Mary Loveless,
and Fred W. Wittich and scientists such as Merrill Chase in the
United States, William Frankland in the United Kingdom,
Pasteur Valéry-Radot and Bernard Halpern in France, and Maur-
icio Rocha e Silva in Brazil, the concept of allergic diseases
based on similar pathophysiological mechanisms emerged.
These diseases affected different organs, such as the nose (rhi-
nitis), the lungs (asthma), the skin (urticaria, atopic eczema, and
contact dermatitis), the eye (conjunctivitis), or the cardiovascular
system (anaphylaxis). Hence, various medical specialists (der-
matologists, internists, otorhinolaryngologists, and ophthalmol-
ogists) were primarily involved in their diagnosis and treatment.
Around 1950, nobody had been primarily or exclusively trained
as an allergist. And it is the discovery of various biological
phenomena (reaginic antibodies: Prausnitz and Küstner; antigens
and antibodies: Landsteiner and Heidelberger; allergens: Black-
ley and Haurowitz; and sensitized lymphocytes: Chase) under-
lying the various clinical phenomena that really created some
unity of thinking and provided the emergence of allergy as a
medical and scientiﬁc discipline. Among the biologists involved,
many had been trained in microbiology because that ﬁeld had
already been familiar for half a century with the notions of
antigens, antibodies, and immunity.
These were exciting times because each year provided
some new building blocks to add to what soon seemed as a new
pyramid of knowledge and as a coherent system. I became
personally involved early in 1953 because in view of a medical
experimental thesis,5 I became one of the ﬁrst to reproduce
and document histologically the classical transfer of contact
dermatitis by sensitized lymphocytes in guinea pigs, originally
described by Merrill Chase in 1942. This was the ﬁrst exper-
imental demonstration that lymphocytes are involved in immu-
nological allergic sensitization. It is this work that launched my
own interest and career in allergy and immunology.
But at that time, a number of older and scientiﬁcally
renowned people had already generated the vision of allergy
and immunology, responsible for some common biological
mechanisms and a multitude of clinical consequences. This
became the major impulse in the creation of a new in-
ternational medical and scientiﬁc association, the IAA.
For the ﬁrst 15 years, the sole activity of the IAA was
the organization of a triennial congress, with practically no
activities in between, although formally several committees
were established. Because neither the Executive Committee
of the IAA nor the Special Committees were able to meet
between congresses, there were few practical actions or
consequences. The congresses were largely the responsibility
of the IAA president, and clinicians played a major role. They
also constituted the majority of the attending delegates.
Beyond the congress proceedings, there are only few written
spurs of these activities because there were no centralized
secretariat and no central archives where members of the
Executive Committee could have deposited IAA documents.
1965 to 1980: From Allergy to Immunology
and Back
The history of the years 1950 to 1980 is dominated by
the continuous exchanges between allergy and immunology.
Many basic immunological phenomena in humans were ﬁrst
elucidated by the study of allergic diseases. But experimental
studies in animals and investigations in humans of various
pathologies, such as autoimmune diseases, hematological
diseases, neurological diseases, or transplant rejection, soon
revealed some common lines of thought. During the ﬁrst IAA
congresses, the programs were therefore very broad and
encompassed the whole range not only of clinical allergy but
also of basic and clinical immunology. This process found its
culmination in the change of name from IAA to IAACI. After
several years of discussion, this change of name was ﬁnally
ofﬁcially endorsed at the X International Congress of
Allergology and Clinical Immunology in Jerusalem in 1979.
Somewhat ironically, the new claim by allergologists to
accommodate and include clinical immunology coincided
with the foundation of several international societies and
groups postulated to represent directly the communities of
scientists and physicians dealing with various aspects of
clinical immunology. The most important were the Interna-
tional Union of Immunological Societies (IUIS, founded in
1970), the Transplantation Society (founded in 1966), the
Clinical Immunology Society (founded in 1987), and the
Federation of Clinical Immunology Societies (founded in
2001). During the 1970s and 1980s, a close cooperation and
interaction developed between the IAACI and IUIS, which I
personally supervised in many ways, having actively partic-
ipated in the foundation of the IUIS as its ﬁrst secretary-
general and being on the Executive Committee of the IAACI
and on the Executive Council of the IUIS at the same time.
This close collaboration found a strange peak since I was for 1
year (1985–1986) president of both organizations for 1 year
(1985–1986). This also found its expression in several com-
mon projects, such as allergen standardization and close
cooperation with the World Health Organization (WHO). At
that time, a number of allergology leaders were also involved
in basic immunological research and immunology circles at
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the national and international levels. Later on, these types of
personal interactions became less frequent. At the organization
level, the current successor of the IAACI, the WAO, seems to
follow separate ways and interests than mainstream immunol-
ogy, with the possible exception of some national societies
(eg, Switzerland) where allergologists and immunologists
have remained together within the same organization.
Beyond being a markedly scientiﬁcally integrative
meeting, the IAA congress in Montreal in 1967 was also
the ﬁrst organized by a professional organization, which then
remained at the service of the IAA as a professional executive
secretary (Suzanne K. Edwards), ensuring in future years and
IAA congresses an administrative and organizational conti-
nuity. These developments shall be further detailed below.
1980 to 1995: Developing Recognition and
New Tools for Allergologists
Beyond continuing its successful series of high-standing
triennial scientiﬁc congresses of the IAACI with an ever-
growing attendance, mainly composed of clinical allergolo-
gists, that period was characterized by an increasing attention
to practical problems arising from the worldwide practice of
allergy. From the steadily increasing number of delegates
attending the ICACI congresses (Table 1) and of national
allergy (and clinical immunology) societies (Table 2), it is
clear that allergology became, during that time in many coun-
tries, a new and fully established branch of clinical medicine.
This process of recognition was very heterogeneous; it was
also often resisted by other medical societies and organiza-
tions. At the teaching and training levels as well, appropriate
teaching and training in allergology were sometimes difﬁcult
to establish at the university and medical faculty levels. Now-
adays, the process is still not fully completed or satisfactory
worldwide.
Nevertheless, the IAACI achieved marked successes at
that time in the recognition of allergology and clinical
immunology, often in cooperation with the WHO. The IAACI
also organized during that period several seminal meetings,
providing guidelines for national governments.
At the time, various practical problems were also
impairing the practice of allergy. A major one was the
quasi-absence of standardization of allergen extracts, the
basic ingredients for allergy practice. Methods of preparation
and quantitative evaluation (unitage), and analytical tools and
techniques, were varying widely from one country to another
and even within countries. Allergen manufacturers were more
or less left free to introduce widely different products in their
markets, and regulatory agencies were not in a position to
efﬁciently fulﬁll their role, which is primarily to protect the
patients. As a result, allergen extracts in the market for
diagnosis and therapy could, under the same unitage label (eg,
in Noon units), differ in biological potency by a factor of
1000! This could have severe clinical consequences, such as
anaphylactic shock by overdosage.
Although standardization of biological materials, in
particular allergens, had gathered attention before and had
been addressed by various groups, this topic had remained
until the end of the 1970s, largely an academic exercise with
little concrete impact on the daily practice of allergology. The
approach changed drastically in 1977, where a joint Allergen
Standardization Committee was set up by the IUIS and
IAACI, with the aim of taking concretely in hand the problem
of allergen standardization. The purposes were to harmonize
and set up ofﬁcially standard methods for qualitative and
quantitative evaluation of allergens, to produce international
allergen standards available to everyone for comparison and
reference, to provide a worldwide system for potency
evaluation (unitage), and in general to foster research on
allergens and allergen identiﬁcation. These were indeed
ambitious goals. For the ﬁrst time, professional associations
were taking in hand directly the production of tools useful for
manufacture, quality control, and regulation and indirectly
therefore also for the beneﬁt of the consumers, that is, doctors
and patients. To achieve these goals, the setup of the
committee was also unheard of and original: it was consti-
tuted in about equal parts of manufacturers, regulators, and
scientists working in the allergen ﬁeld and from interested
consumers, that is, clinical allergologists.
A new and original feature was also that for the ﬁrst time
in allergy history, a real dialogue developed between American
and European allergologists, manufacturers, and regulators on
these matters. The contributions of Harold Baer, director of the
Federal Drug Administration’s Biological Research Section,
and Robert A. Goldstein from the National Institute of Allergy
and Infectious Diseases for the American side and Bernard
Guérin, Jean Bousquet, A. Ford, B. Brighton, and Henning
Löwenstein from the European side were quite decisive in
the intense activities of the IUIS/IAACI Allergen Standardiza-
tion Committee during the 1980s.
A ﬁrst line of activity was the development of new
quantitative and qualitative methods of allergen evaluation
(eg, radioallergosorbent inhibition, immunoblotting, enzyme-
linked immunosorbent assay) better related to the pathophys-
iology of allergic diseases. The methods were then validated
at the international level by coordinated collaborative studies
and adopted as methods of reference. In a second phase, with
TABLE 1. Summary of IAACI Congresses, Attendance,
Budget, and Financial Outcome
IAACI Congresses
(1951–1997) Attendance Budget Proﬁt (Loss)
Zürich (1951) 470 d d
Rio de Janeiro (1955) 350 d d
Paris (1958) 1400 d d
New York (1961) d d d
Madrid (1964) 1300 d d
Montreal (1967) 1400 $108,000 $(12,720)
Florence (1970) 1640 $132,000 $15,271
Tokyo (1973) 1760 $382,000 $6,397
Buenos Aires (1976) 1200 $210,000 $(36,500)
Jerusalem (1979) 1300 $285,000 $17,827
London (1982) 2350 $712,000 $76,277
Washington (1985) 3023 $1,500,000 $123,000
Montreux (1988) 5687 $2,280,000 $190,000
Kyoto (1991) 3000 $2,880,000 $38,212
Stockholm (1994) 6200 $2,300,000 $325,400
Cancun (1997) 4183 $2,749,000 $558,500
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TABLE 2. IAA/IAACI Member Societies (1951–2010)
Founded in IAACI Member Since
Members
20001979 1982 1988 1991 1997/1998
Member societies IAACI
Albanian Society of Allergology and Clinical
Immunology
d d d d d d 60 60
AAAAI 1943 1951 F* 2588 2740 d 4277 3481* 5700
American College of Allergy, Asthma and
Immunology
1942 1951 F 1764 1704 d 3425 1677 1677
American Society of Ophthalmologic and
Otolaryngologic Allergy
d 1951 F d d d d d d
American Association of Immunology d d 647 629 d d d d
Argentine Association of Allergy and
Immunology
d 1951 F 124 131 66 97 358 161
Argentine Society of Allergy and
Immunopathology
d 1951 F d 49 d 24 72 200
Australasian Society of Clinical Immunology
and Allergy
1953/1991 1951 F 112 70 128 171 154 d
Austrian Society of Allergology and Immunology 1971 d d d d d 407 670
Azerbaijan Society for Asthma, Allergy and
Clinical Immunology
d d d d d d d d
Bangladesh Society of Allergy and Immunology d d d d d d d d
Belgian Society for Allergy and Clinical
Immunology
1980/1996 1951 F 185 187 192 190 100 100
Bolivian Society of Immunology d d 19 19 d d d d
Brazilian Society of Allergy and
Immunopathology
1946 1951 F 278 378 d 310 1010 1300
British Society for Allergy and Clinical
Immunology
1948/1962 1951 F 299 321 280 400 483 523
Bulgarian Society of Allergology d d d d d d d d
Canadian Society of Allergy and Clinical
Immunology
1945/1967 1951 F 174 172 162 198 301 d
Chilean Society of Allergy and Immunology 1946/1978 1951 F 53 60 60 91 90 137
Chinese Society of Allergology d d d d d d 12 1000
(Chinese) Hong Kong Institute of Allergy d d d d d d d d
Colombian Allergy, Asthma, and Immunology
Association
d 1951 F d d d d 106 d
Croatian Society of Allergology and Clinical
Immunology
d d d d d d d d
Cuban Society of Allergy, Asthma and Clinical
Immunology
d 1951 F 6 6 32 32 30 d
Cyprus Society of Allergology and Immunology d d d d d d d d
Czech Society of Allergology and Clinical
Immunology
d d d d d d d d
Danish Society of Allergology 1946 1951 F 208 236 239 367 435 d
Ecuadorian Society of Allergology and Afﬁliated
Sciences
d d 25 18 24 24 20 30
Ecuadorian Society of Allergy and Immunology d d 10 19 21 12
Egyptian Society of Allergy and Clinical
Immunology
d d 23 23 65 60 75 d
Egyptian Society of Pediatric Allergy and
Immunology
2002 d d d d d d d
Finnish Society of Allergology and Clinical
Immunology
d 1951 F 144 166 212 258 335 346
French Society of Allergology d 1951 F 695 649 907 794 830 d
Groupement des Allerfgolohistes de Langue
Francaise
d d 164 153 d d d d
Georgian Association of Allergology and Clinical
Immunology
d d d d d d d d
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TABLE 2. (Continued)
Founded in IAACI Member Since
Members
20001979 1982 1988 1991 1997/1998
German Society for Clinical and Experimental
Immunology (DDR)
d d 154 153 d d d d
German Society for Allergology and Clinical
Immunology
1951 1951 F 160 157 324 350 488 d
Hellenic Society of Allergology and Clinical
Immunology
1973 d d d 15 d 53 d
Honduran Society of Allergy and Clinical
Immunology
d d d d d d d d
Hungarian Society of Allergology and Clinical
Immunology
d 1951 F d d 24 d 351 400
Icelandic Society of Allergy and Immunology d d d d d d d d
Indian College of Allergy, Asthma and Applied
Immunology
1967 d 65 62 90 78 119 400
Indonesian Society for Allergy and Immunology d d d d d d d d
Iranian Society of Allergy d d 14 19 18 20 20 d
Israel Association of Allergy and Clinical
Immunology
d 1951 F 40 31 63 70 78 d
Italian Association of Territorial and Hospital
Allergists
d d d d d d d d
Italian Society of Allergy and Clinical
Immunology
d 1951 F 185 183 655 1226 545
Japanese Society of Allergology d 1951 F 392 459 488 4758 6787 7000
Korean Academy of Allergy, Asthma and Clinical
Immunology
d d d d 140 145 305 303
Latvian Association of Allergists d d d d d d d d
Lebanese Society of Allergy and Immunology d d d d d d d d
Malaysian Society of Allergy and Immunology 1998 d d d d d d d
Mexican College of Clinical Immunology and
Allergy
d 1951 F d d d d d d
Mexican Society of Allergy and Related Sciences d d 32 31 26 55 200 d
Mexican College of Pediatricians Specialized in
Allergy and Clinical Immunology
1989 d d d d 100 122 d
Mongolian Society of Allergology d d d d d d d d
Netherlands Society of Allergology d 1951 F 93 127 54 23 30 d
Norwegian Society of Allergology and
Immunopathology
1946 d 109 177 218 220 346 350
Panamanian Association of Allergology and
Clinical Immunology
d d d d d d d d
Paraguayan Society of Immunology and Allergy d d 7 9 11 15 22 d
Peruvian Society of Allergy and Immunology d 1951 F 30 30 4 15 51 d
Philippine Society of Allergy, Asthma and
Immunology
1972 d 11 10 10 23 44 51
Polish Society of Allergology 1982 d d d 17 d 425 674
Portuguese Society of Allergology and Clinical
Immunology
d 1951 F 51 51 31 210 196 300
Romanian Society of Allergology and Clinical
Immunology
1990 d d d d d d 100
Russian Association of Allergology and Clinical
Immunology
d d d d d d d d
(Singapore) Allergy and Clinical Immunology
Society
d d d d d d d d
Association of Allergy & Clinical Immunology of
Serbia & Montenegro
d d d d d d d d
Slovenian Association for Allergology and
Clinical Immunology
d d d d d d d d
Allergy Society of South Africa d 1951 F d d d d 350 d
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the cooperation and ﬁnancing of the industry, several
candidate reference allergen extracts were evaluated and
characterized by multiple studies at the international level
under the supervision of the WHO. Some suitable prepara-
tions obtained the status of WHO International Standards;
others considered as not fully representative of the whole
spectrum of individual allergenic molecules, which should be
present in a biologically active extract, were merely consid-
ered as International Reference Preparations.
This considerable scientiﬁc, ﬁnancial, and logistical
effort remains, in my historical view of the development of
allergology and immunology, the most remarkable instance
where consumers, manufacturers, and regulators took jointly,
and at the bench level, their fate in their own hands with the
common purpose to improve service to the patients. It is
somehow regrettable that these efforts, although provided
with enthusiasm by the participants, were not fully crowned
by success.
TABLE 2. (Continued)
Founded in IAACI Member Since
Members
20001979 1982 1988 1991 1997/1998
Spanish Society of Allergology and Clinical
Immunology
d 1951 F 304 358 525 634 d 600
Allergy & Immunology Society of Sri Lanka d d d d d d d d
Swedish Association of Allergists d 1951 F 211 206 263 d 568 640
Swedish Association of Internal Allergy d d d d d d d d
Swiss Society for Allergology and Immunology 1950 1951 F 226 213 353 470 450 462
Allergy, Asthma and Immunology Society of
Thailand
d d d d d d d 150
Turkish National Society of Allergy and Clinical
Immunology
1995 d d d d d d d
Ukrainian Association of Allergologists and
Clinical Immunologists
d d d d d d d d
Uruguayan Society of Allergology d 1951 F 18 16 18 10 104 d
Venezuelan Society of Allergy and Immunology d d d d 9 88 96 d
Vietnam Association of Allergy, Asthma and
Clinical Immunology
d d d d d d d
Yugoslavian Society of Allergology d d 256 253 11 d d d
Zimbabwe Allergy Society d d d d d d d d
Associate member societies d d d d d d d d
National Association for Private Algerian
Allergists
2002 d d d d d d d
Ecuadorian Society of Allergy and Immunology d d d d d d d d
Ecuadorian Society of Allergology and Afﬁliated
Sciences
d d d d d d d d
Jordanian Society for Allergy and Clinical
Immunology
d d d d d d d d
Kuwait Society of Allergy and Clinical
Immunology
d d d d d d d d
Moroccan Society of Allergology and Clinical
Immunology
1992 d d d d d d d
Swedish Association for Allergology d d d d d d d d
Regional organizations d d d d d d d d
Asia Paciﬁc Association of Allergy, Asthma and
Clinical Immunology
1989 1997 d d d d d
Commonwealth of Independent States Society of
Immunology and Allergology
d d d d d d d d
EAACI 1956 d d d d 1250 3500 d
Latin American Society of Allergy, Asthma and
Immunology
d d d d d 1224 3100 d
Afﬁliate organizations
GA2LEN (Global Allergy and Asthma European
Network)
d d d d d d d d
International Association of Asthmology 1954 d d d d d 4000 d
International Primary Care Respiratory Group d d d d d d d d
Southern European Allergy Societies d d d d d d d d
Compiled by the author.
*An F by the year in the second column indicates a founding member society.
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The main intent of the allergen standardization project
started jointly by the IAACI and IUIS in 1977 had been to
establish identical criteria worldwide for evaluation of quality
and potency of allergen extracts, including their regulation for
use. For that purpose, a collection of internationally recog-
nized Reference Standards had to be established as well. We
must unfortunately recognize that, 30 years later (!!!!!), this
goal has still not been achieved. From my own perspective,
the main cause for that failure is that the initial tacit agreement
between the Food and Drug Administration (FDA) in the
United States and various European national regulatory
authorities to harmonize methods and regulations dissolved
in thin air around the end of the 1980s. This was due to
several related factors. The ﬁrst dent in the wall was the
observation that some of the allergen preparations selected as
WHO International Standards were not perfect and showed
some technical ﬂaws. Instead of being positive about having
a usable Reference Standard at all, some found it more
rewarding to emphasize more or less minor defects. From
there on, it was a natural trend for some regulators, who by
deﬁnition must be overcautious, to put in doubt the feasibility
of the whole process. The state of legislation and regulation
for allergenic products was also at the time still very
heterogeneous throughout the world. For the USFDA, obliged
by law to regulate allergens, it became somehow inconceiv-
able to have to wait and depend on a slow international
harmonization process. Accordingly, the FDA soon went
ahead with its own methods, allergen standards, and regu-
lations. The Europeans, on the other hand, endeavored to
harmonize various national regulations into a single European
directive under the sponsorship of the European Pharmaco-
poeia. Therefore, although the whole effort had undeniably
a very positive effect in improving the quality and the
manufacturing processes of allergen extracts put on the
market, it did not achieve its original purpose: worldwide
standardization.
An additional factor became the demotivation of
essential partners, the allergen manufacturers. At the start,
the motivation of the allergen manufacturers for technical and
ﬁnancial support had been to foster worldwide rules for
evaluation and registration of allergens, a potent means to
improve efﬁciency and reduce costs. When they saw,
however, that the rules of the game would continue to
diverge in their various markets, motivation faded. On the
contrary, the regulation gaps were suddenly perceived by
some as a potent opportunity to provide their own evaluation
criteria and their own potency unitage, posturing quality
control as an effective marketing tool. Because units provided
by different manufacturers were not equivalent, the ﬁnal
result was on the one hand a greater heterogeneity than
before, a fair degree of confusion and a welcome (by the
companies!) loyalty on the part of consumers. The whole
process favored also a concentration among manufacturers
because many small companies existing in the 1970s could no
longer follow the game.
Even if the enthusiasm of the early 1980s for allergen
standardization slackened within the next 10 years, the IAACI
remained actively involved in the development and harmoni-
zation of new technologies for that purpose. Molecular
investigations on the structure of allergenic epitopes, pro-
duction of monoclonal antibodies against allergens, and
production of recombinant allergens became new tools
opening much better technological perspectives. In that spirit,
the IAACI organized and supported specialized meetings and
technical courses on molecular biological technology applied
to allergens. There again, emphasis was put on a close
cooperation between scientists, manufacturers, and regulators.
During the period of 1980 to 1995, the IAACI also
pursued, beyond the organization of its triennial congresses,
also other strategic goals, all based on practical needs and
improvements in the practice of allergy. Among these was
a series of specialized workshops and international studies on
house dust mite allergy. House dust mites were recognized as
a main cause of allergic asthma worldwide, but the knowl-
edge about their physiology, their habitat, the better ways to
combat them, the factors inﬂuencing their pathological role,
and so on, was disseminated among different professional
lines (entomology, climatology, household technology, insect
control, immunology, and allergology), which had little
opportunity to meet. There was also no particular incentive
for the pharmaceutical industry to foster such a line of work.
The IAACI activities had therefore a seminal role in
improving not only our knowledge about house dust mite
allergy but also new and optimal solutions to that worldwide
problem, which affects millions of patients.
Although around 1980, allergy as a medical discipline
and specialty was well recognized in a number of countries,
there was still much to do in terms of medical training,
specialization, and ofﬁcial recognition in many parts of the
world. This aspect, recognition of allergy at the medical school
and public health levels, became also at that time an important
strategic goal for the IAACI. In close cooperation with the
WHO, several initiatives in that direction were taken, such as
the IAACI Committee on Specialization and Training. I have
little doubt that these initiatives produced adequate fruits within
10 years, as shown by a literal explosion of allergy groups and
national societies in the 1990s and 2000s. Of course, the
marked epidemiological increase of allergic diseases during the
same period has also contributed to the increased recognition
of allergy as a public health problem.
1995 to 2000: Toward a World
Allergy Organization
The relatively closely knit group of IAACI presidents
and Executive Committee members, who were mostly heavily
engaged in allergology practice, had opened since 1980 the
door of ICACI scientiﬁc congresses to other purposes than
mere scientiﬁc exchanges. These lateral activities had, how-
ever, a limited scope. First, they were devoted to goals, which
had possibly a broad clinical impact, such as standardization or
mite allergy, but which were involving only a limited number
of highly specialized individuals. Second, these activities were
hardly attractive or important for the pharmaceutical industry,
and it was difﬁcult to ﬁnd ﬁnancial sponsors.
At the same time, the character and needs of ICACI
congresses began to change. In the early days, the main or
sole purpose was a multidisciplinary exchange of scientiﬁc
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information among professionals who, for the most part, had
not been primarily trained as allergists. Then, increasingly,
generations of physicians and biologists primarily trained in
allergy found in IAACI and in their national allergy societies
their sole professional family. These had therefore to satisfy
not only scientiﬁc but also professional needs, particularly in
terms of postgraduate education, postgraduate courses, and
the like.
It was also soon realized that, particularly in view of
allergic diseases becoming a growing public health problem,
the small number of specialized allergists would never sufﬁce
to ensure appropriate diagnosis and treatment of millions of
allergic patients worldwide. For that purpose, it was impera-
tive to provide proper education on modern allergy concepts
and techniques to related medical specialties (pneumologists,
internists, pediatricians, dermatologists, otorhinolaryngolo-
gists, and ophthalmologists) but also and foremost to general
practitioners. Last but not least, it was necessary to provide
allergy education to paramedical personnel (nurses), to
teachers and parents of allergic children, and to the allergic
patients themselves. This represents an enormous task
worldwide and a quasi-total departure from the former limited
frame of IAACI as a scientiﬁc and medical association.
This evolution represented also playing in a different
league in terms of logistics and economics. Since 1993, the
IAACI developed together with pharmaceutical industrial
partners ambitious educational programs [eg, World Allergy
Forum, Perspectives of Allergy (see section on Special
Projects and the WHO)] aimed at a broader audience and
costing several hundreds of thousands of US dollars. These
also required increasing professional administrative support.
Broad ﬁnancial support from the industry was easier to obtain
because the drug allergy market represented around US $20 to
US $30 billion worldwide and because the IAACI-sponsored
programs represented an ideal marketing tool. To improve
legitimacy and worldwide access to such programs, ofﬁcial
partnership with the WHO was also sought.
These trends and activities had many visible and
positive effects, such as better recognition of allergy as
a public health problem and better acceptance of allergy as
a specialty in medical schools, improvement of allergy
education in other medical specialties and broader public
closer ties between IAACI and its national member societies,
involvement of a larger number of young professionals in
educational activities, creation of educational materials, and
a sizable increase in ﬁnancial capacities of IAACI organiza-
tions and congresses. Indeed, since 1987, attendance and
budgets of the congresses increased markedly from less than
$1 million to nearly $3 million, with sizable beneﬁts rein-
vested in educational and other projects (Table 1). There is
also little doubt that the general climate created by this ﬂurry
of IAACI activities has helped to develop the consciousness
of national governments and politicians about allergic dis-
eases. Several allergy-related research and epidemiological
programs have been launched in the years 2000 and beyond,
particularly at the level of the European Union (GA2LEN,
CREATE, PREVALL, etc.).
To better cope with new worldwide responsibilities,
new missions, and a larger ﬁnancial and administrative frame,
a profound reorganization and formulation of a new strategy
were found necessary. Under the leadership of President
S. Gunnar Johansson (1997–2000), several meetings were
organized in 1998 and 1999 to discuss a new strategy for
IAACI, a change of name to WAO, and the necessary adap-
tations and changes of the Constitution and Bylaws. These
represented a profound change in the mission and aims of the
IAACI. From an association of professionals essentially de-
voted to scientiﬁc exchange and internal education, the group
was to become a worldwide organization with a signiﬁcant
inﬂuence on public health and, to some extent, political re-
sponsibilities. In addition, the move implied some new struc-
tural ties with industry sponsors.
In addition to these substantial moves, the proposed
reorganization was responding to some frustrations among the
younger generations about the rigid structure of IAACI,
particularly with the long period in ofﬁce of Executive
Committee members and IAACI ofﬁcers, precluding broader
recruitment, involvement, and turnover of younger leaders.
Indeed, due to the triennial elections, a president was active
for at least 9 years on the Executive Committee, often more.
Accordingly, several alternative solutions for more rapid
turnover and shorter intervals between IAACI congresses
were discussed. Finally, in a new constitution adopted at the
congress in 2000 in Sydney, a biennial rotation for congresses
and Executive Committee elections was adopted.
The full extent of the profound changes proposed was
possibly not perceived at the time by the bulk of IAACI
constituency. They generated a number of cautionary remarks
but no deﬁnite opposition. This is not the place to evaluate
and compare how far the changes in orientation and mode of
operation of the IAACI/WAO from 2000 to 2010 have
successfully and positively inﬂuenced the evolution of allergy
professionals and allergy patients throughout the world (see
Conclusions).
IAACI CONGRESSES
Foundation of the IAACI and I International
Congress of Allergology, Zürich, 1951
The effective foundation of the IAA was prepared for
almost 5 years by intense correspondence, primarily between
the American protagonists (Ethan Brown, Fred W. Wittich,
and Samuel Feinberg), the French (Pasteur Valéry-Radot and
Bernard Halpern), the Spanish (Carlos Jimenez Diaz), and the
South Americans (Mauricio Rocha e Silva). This correspon-
dence, which has unfortunately been lost, but which I had the
opportunity to read some years ago, showed that unity on the
aims and means of the new association was not easy to attain.
In particular, the classical antagonism between American and
French views was already evident at that time. As a matter
of fact, the ﬁnal session leading to the formulation of the
IAA constitution on September 27 and 28, 1951, lasted until
2:00 AM in the morningdlike many later political United
Nations Organization international meetings!
The I International Congress of Allergology was con-
vened in Zürich from September 23 to 29, 1951. It convened
570 participants from 39 countries and 28 national allergy
societies. The congress was organized by Ch. W. Löfﬂer, an
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internationally recognized authority in internal medicine, as
president and A. S. Grumbach, professor of Microbiology, as
secretary-general. The ﬁnances, as expected, were attended by
a Swiss bank, Credit Suisse, in the person of A. G. Mann as
treasurer.
As indicated in the ﬁrst report of the congress, the
organization had to tackle numerous expected difﬁculties.
Although an “IAA” already existed in the United States, it could
hardly be considered as a real lead organization, several impor-
tant national societies having not yet joined. After 3 years of
tiresome correspondence, a personal visit by B. Z. Rappaport,
Chicago, gave the opportunity to convince the leaders of the
American Academy of Allergy and other uninvolved societies
that the future IAA and the congress would be organized as
a gathering of free and independent academicians.
It was especially thanks to the preliminary work done by
Ethan A. Brown and Samuel M. Feinberg that an acceptable
version of the IAA constitution was arrived at overnight from
Thursday to Friday, September 27 and 28 at 2:00 AM. After
its signature by all the delegates who provided credentials
(House of Delegates), the new IAA was proclaimed on Friday,
September 28, at 3:00 AM. The new Executive Committee was
elected (Table 3) under the presidency of Fred W. Wittich, with
S. F. Feinberg as president-elect, B. N. Halpern as secretary-
general, and A. S. Grumbach as treasurer.
The congress was held at the Zürich Congress Building
and was followed by “Symposium on the inﬂuence of the
hypophysis and the adrenal cortex on biological reactions”
sponsored by the Swiss Academy of Medical Sciences.
Therefore, from the beginning, the IAA was associated with
the most modern aspects of allergy, in that case the discovery
of the role of corticosteroid hormones, the most recent med-
ical discovery of the time.
The importance of the new ﬁeld was also recognized by
political authorities, the congress being held under the
patronage of the Swiss Federal Council and the honorary
president being Phillip Etter, head of the Department of the
Interior.
During the congress, honorary membership was
awarded to various illustrious scientists in the ﬁeld of allergy:
• A. F. Coca, New Jersey (United States)
• Sir Henry Dale, London (United Kingdom)
• R. Doerr, Basel (Switzerland)
• C. Frugoni, Rome (Italy)
• D. M. Heidelberger, New York (United States)
• R. Otto, Frankfurt (Germany)
• P. Portier, Paris (France)
• R. Rössle, Berlin (Germany)
• B. Schick, New York (United States).
In the course of the week, 26 reports, 22 opening
lectures, and 132 individual contributions were presented.
The accompanying spouses had also an extensive program,
with a dahlia show, a fashion show at the famous Grieder
House, various private tea receptions at private homes, an
excursion to the Lake Lucerne, and a visit to the Monastery of
Einsiedeln.
As indicated by W. Löfﬂer in his closing remarks, this
ﬁrst meeting of experts on a worldwide basis exceeded the most
optimistic expectations and set the tone for many other fruitful
congresses. The spirit had well changed since a little anecdote
concerning Pirquet and which was recalled by W. Löfﬂer .
Shortly before his death, Pirquet was visited by a colleague
who was also scientiﬁcally interested in allergy. After his
colleague had left, Pirquet said to his assistant, “I don’t like
at all when other people poke their noses in my personal
affairs.” He regarded apparently allergy, in which he was the
pioneer, as an interesting and personal affair.6
As Löfﬂer concluded: The future of allergy research
and understanding are bright and will require participation
of many disciplines. As said by Claude Bernard, science con-
sists not only in facts but also in the conclusions drawn from
them.6
As a sign of changing times, it could also be reminded
that in 1951, thank-yous to the ﬁnancial sponsors were a single
global expression of gratitude toward the “contributing private
enterprises,” and their corresponding advertisements were lim-
ited to a few pages at the end of the congress book.
II International Congress of Allergology,
Rio de Janeiro, 1955
In 1955, the IAA encompassed 28 regional societies
and a total of 3450 members. Its second international meeting
was held from November 6 to 12, 1955, in the magniﬁcent
hotel of Quitandinha located in Petropolis, about 60 km
from Rio de Janeiro, in half-tropical, half-mountainous
surroundings.
The organization of the congress had been assumed by
the Brazilian Society of Allergy and Immunopathology, under
the presidency of Francisco E. Rabello, a well-known
dermatologist, and with Ulysses Fabiano Alves as secretary-
general. The Organizing Committee was chaired by E. Bruun
Negreiros. Twenty-six countries had sent delegations, and the
number of attendees was about 350.
Six honorary lecturers had been invited: Sir Henry H. Dale
(United Kingdom), Pasteur Valéry-Radot (France), Robert
Cooke (United States), Bernardo Houssaye (Argentina), Jimenez
Diaz (Spain), and Mauricio Rocha e Silva (Brazil). Unfortu-
nately, neither Sir Henry Dale, Pasteur Valéry-Radot, nor
Bernardo Houssaye could attend the congress.
The languages mostly used during the congress were
English, French, Portuguese, and Spanish, with simultaneous
translation provided. The congress was opened Sunday,
November 6, with ofﬁcial addresses from Dr Carlo Luz,
president of the Federal Chamber of Representatives, Dr Nerou
Ramos, vice president of the Senate, and Dr Aramis de
Athayde, Minister of Health.7
III International Congress of Allergology,
Paris, 1958
The III International Congress of Allergology was held
in Paris within the facilities of the new Faculty of Medicine,
rue des Saints-Pères, from October 19 to 26, 1958, and gath-
ered about 1400 participants, representing 41 countries (Fig. 1).
Pasteur Valéry-Radot was honorary president and Samuel M.
Feinberg, president of the IAA, chaired the congress. The
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Organizing Committee was composed of Bernard N. Halpern
(president), Andrée Holtzer (secretary), Pierre Blamoutier (trea-
surer), and P. Grabar and E. Sidi (members).8,9
The opening session was presided by Jean Berthoin,
Minister of National Education, Bernard Chenot, Minister of
Public Health, Jean Sarrailh, rector of Paris University,
Léon Binet, dean of the Faculty of Medicine, and Sir Henry
H. Dale, from London, winner of the Nobel Prize of Medi-
cine, as well as Paul Portier of the Academy of Sciences and
also a Nobel Prize winner. In his opening talk, Paul Portier, in
moving words full of humility and simplicity, recalled the
circumstances of the discovery of anaphylaxis by Charles
Richet and himself during the famous 1901 cruise on the
yacht of Prince Albert I of Monaco. Very moved, the audi-
ence gave a standing ovation to this great scientist, 93 years of
age, when ending his talk, he stated: “This is the history of the
big discovery made together with Mr Richet, a little bit de-
spite ourselves.”8,9
Sixty-four lectures were presented in the frame of 7
symposia devoted to asthma and emphysema, physicochem-
ical properties of allergic antibodies, recent advances in
etiology and treatment of allergic diseases, biochemical
aspects of hypersensitivity, auto- and isosensitization, eczema
diathésique (atopic dermatitis), and allergy and its social im-
pact in various countries. About 400 scientiﬁc communica-
tions were presented by the participants on various problems
related to allergy.8,9
Problems related to allergy concern not only human
clinical diseases. These represent only a single aspect of that
ﬁeld. The immunological mechanism of the allergic reaction
has indeed a much broader signiﬁcance. Allergy is only
a form of immunity, characterized essentially by the pro-
duction of a special type of antibody able to bind to tissues.
As a result of the reaction between the speciﬁc antibody and
the antigen, which has caused its formation, an explosive
liberation of cellular histamine occurs, which is responsible
for the clinical symptoms.9
It seems, as shown by various studies presented at that
congress, that some not yet fully known diseases, in particular
some blood diseases affecting erythrocytes, platelets, or
leukocytes, are based on a mechanism of auto- or isosensi-
tization. This may also be the case for some so-called
collagen diseases, lupus erythematosus, periarteritis nodosa,
acute rheumatoid arthritis, scleroderma, and dermatomyositis.
Although it seems unlikely that all these diseases represent
the clinical expression of a single identical immunological
response, convincing evidence has been provided that they
rest on an immunoallergological mechanism. In this last
group of diseases, the role of chemical mediators is more
doubtful, and cellular lesions are caused by activation of
serological and tissue complement acting as a real enzyme.9
On the other hand, it is currently obvious that the
organism rejects transplanted organs or homologous grafts by
similar mechanisms. The solution of the important and
pressing question of graft and organ transplantation rests
entirely on progress gained in knowledge about immunolog-
ical and allergic phenomena and in the possibility of
preventing the formation of the antitissue antibodies
responsible for graft rejection.9 Drug allergy also held a major
place in the discussions due to its increasing incidence and to
the severe effects, sometimes fatal, which it may cause.9
Finally, a new problem that affects mainly the organism
of public health and social security is the social and economic
impact of allergic diseases in various countries. The impor-
tance of this issue is underlined by some numbers. More than
9 million working days are lost annually in Great Britain due
to allergic diseases. In Belgium, for a population of 9 million
inhabitants, the cost of respiratory allergic diseases amounts
to 18 billion French francs per year, which extrapolated to the
French population would mean for France a yearly expense of
90 billion French francs, and this only for respiratory allergic
diseases.9
By order of prevalence, allergic diseases come in third
place behind cancer and cardiovascular diseases, and they
affect about 10% of the population. Their incidence is steadily
increasing. Whereas cancer and cardiovascular diseases
usually touch individuals in a declining phase of activity,
allergic diseases may start in the cradle and pursue people
during their whole life.9 It is time that the authorities respon-
sible for public health give more attention to this important
FIGURE 1. Cover of the ﬁnal program of the III International
Congress of Allergology, Paris, 1958.
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question that raises social, prophylactic, educational, and also
ﬁnancial problems.9
IV International Congress of Allergology,
New York, 1961
The IV International Congress of Allergology was held
at the Hotel Commodore in New York from October 15 to 20,
1961, under the chairmanship of Bernard N. Halpern. This
international conference was becoming increasingly impor-
tant as a means of assembling and presenting advances in
medical knowledge and the latest work on a fascinating
subject. A broad view had been increasingly taken of allergy.
Consequently, the 43 main papers dealt with a great variety of
subjects. It is this recognition of allergy as a phenomenon
with an inﬁnite number of facets and as the main ingredient of
many different clinical conditions that makes the ﬁeld so
important. The fact that autoimmune disease, hypogamma-
globulinemia, and homograft rejection are discussed in the
same section shows how we have moved since the days when
asthma, hay fever, and eczema were the only allergic
disorders known to most physicians.10
Many of the papers presented were perhaps fully
comprehensible only by the biochemists. They gave the latest
information about the biochemistry of the antigen–antibody
reaction and the identity of its mediators, an admittedly un-
ﬁnished but rapidly unfolding story, but there was also much
information available for the clinician, in particular, an excel-
lent exposition of hypersensitivity to drugs, of the manage-
ment of asthma, and of the use of mineral oil emulsions for
desensitization to pollens.10
V International Congress of Allergology,
Madrid, 1964
A highly successful V International Congress of Aller-
gology was held in Madrid, Spain, in October 1964 under the
presidency of Carlos Jimenez Diaz and with F. Lahoz as
organizing secretary (Fig. 2). It attracted approximately 1300
participants from 50 countries and many guests and exhibi-
tions. At the main scientiﬁc sessions, simultaneous translation
facilities were available in Spanish, English, French, and Ger-
man, the ofﬁcial languages of the congress.11,12
The general topics discussed at the congress were the
relationship between allergy and immunity, bronchial asthma,
and diseases of autosensitization. B. B. Levine of New York
read an interesting paper on immunochemical mechanisms
involved in penicillin hypersensitivity in experimental ani-
mals and human beings. A paper on cellular and humoral
theories of anaphylaxis was presented by H. O. Schild of the
London University College. W. B. Sherman from the Cook
Institute of Allergy in New York spoke about antibodies of
inhuman allergic diseases.11
Antigens and antibodies in drug allergy were discussed
by Max Samter and S. A. Markowitz from Chicago. They
stated that the antigens in drug allergy are by and large
antigenic determinants attached to protein carriers. Clinical
differences in drug reactions might be due to the differences
in host response to the antigen–antibody complex and to the
type of antibodies.11
Hans Selye from Montreal presented a paper on
calciphylaxis and calcergy. He made an attempt to present
a natural classiﬁcation of the various forms of calciphylaxis
and calcergy. Although little is known as yet about calciphy-
laxis in humans, the possible clinical implications of these
concepts have provided very interesting and promising
problems for future investigation, as judged at the time,
although calciphylaxis 50 years later seems to have largely
disappeared from the scene.11
Cournand from New York discussed pulmonary me-
chanics, gas exchanges, and circulation during acute bouts of
asthma and intervening periods. E. Witebsky from Rochester
presented the meaning of autoantibodies in human pathology,
a compilation of work in the ﬁeld of autoimmune diseases.
Several interesting papers were presented on the connection
between the thymus and autoimmunity.11 The congress was
FIGURE 2. Cover of the ﬁnal program of the V International
Congress of Allergology, Madrid, 1964.
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a highly successful one, considering the scientiﬁc value of the
papers presented, the thoroughness with which the selected
topics and general themes were covered, the general organi-
zation of the congress, and the various social and parascien-
tiﬁc activities.11
Author’s Personal Note
For me, this congress was a marking stone because it
was the ﬁrst IAACI congress that I attended and also my ﬁrst
big allergy congress at all. I was struck by the opportunity to
meet many scientists known until then only from literature, an
opportunity even more fruitful than listening to many in-
teresting papers. It was also the ﬁrst opportunity to present at
the international level the basic work on penicillin allergy and
immunohistochemistry performed in the preceding years by
B. B. Levine, myself, and C. Parker in Herman Eisen’s group.
It is from there on that my interest in IAACI originated and
my conviction that the IAACI was to be the main vehicle of
progress in allergology in the subsequent years.
VI International Congress of Allergology,
Montreal, 1967
The VI International Congress of Allergology was held
in Montreal from November 5 to 10, 1967, under the
presidency of Bram Rose and with S. O. Freedman as
secretary-general of the Organizing Committee. There were
about 1400 attending delegates.13–15
The ﬁrst major symposium dealt with the cells that are
now regarded as the hallmarks of immune processes.
J. F. A. P. Miller (Melbourne) outlined the evolution of the
progenitor stem cell from its origin in bone marrow to its ﬁnal
sophisticated role as an antibody-forming cell in the lymph
node via thymus lymphocytes and the circulating pool of
long-living antigen-reactive and antibody-forming cells.
G. Mackaness (Saranac Lake) described how mononuclear
phagocytes or macrophages engulfed antigenic material by
pinocytosis into its pinocytic particles or pinosomes and then
transferred it to lysosomes. These organized packages of
enzymes then degraded antigen to its constituent nucleic
acids, although the fate of the latter was not clear. Anti-
lymphocytic serum and irradiation have been found to
stimulate pinocytosis of macrophages and help destroy
antigenicity. M. Litt (Boston) had studied the effect of
inoculating the footpad of the guinea pig with hemocyanin
or chick erythrocytes, which produced eosinophils in the
draining lymph nodes within minutes. This reaction was
suppressed by cyclophosphamide and is probably due to an
antigen–antibody reaction.13
In the ﬁeld of transplantation, R. Billingham (Philadel-
phia) reported that homograft rejection followed the intimate
admixture of the graft antigen with sensitized lymphocytes but
some other factor, such as a lymph node plasma factor, which
appeared early and governed migration of macrophages also
contributed. During the past 4 years, Montreal’s McGill Uni-
versity had transplanted cadaver kidneys to 79 patients with
renal failure, most of whom were younger than 45 years. The
preparatory immunosuppressive regimen to overcome homo-
graft rejection included local irradiation, oral corticosteroids,
azathioprine, and actinomycin. Complications after operation
included rejection, acute tubular necrosis, and vascular upsets.
In his detailed review of this considerable experience,
J. Dossetor (Montreal) pointed out that previous sensitization
by hemodialysis was not deleterious to subsequent renal
transplantation. The 2-year survival rate was 40%. T. Starzl
(Denver) emphasized the immunosuppressive value of antilym-
phocyte serum prepared by subcutaneous injection of human
spleen into horses. The harvested antilymphocyte serum,
inoculated subcutaneously into renal graft recipients, behaved
synergistically with oral corticosteroids and azathioprine, so
that their dose could be halved. Although there had been a sur-
vival rate of about 50% before the availability of antilympho-
cyte globulin, only 1 of 20 patients had died since its
introduction 17 months before. Moreover, before July 1987,
all 7 patients who had received liver homotransplants had died.
Since then, with the help of antilymphocyte globulin, 3 of 4
patients had survived more than 2 months. However, antilym-
phocyte globulin was not without risks: serum sickness, ana-
phylactic reactions, fever, and pain at the site of injections, but
at that time, no serum sickness nephritis had been reported after
more than 2500 injections.13
In a session devoted to sarcoidosis, E. Mankiewicz
(Montreal) reported the frequent isolation of mycobacteria and
their phages from serum and specimens resected from patients
with sarcoidosis. Serum antibodies to these mycobacteriophages
were readily demonstrated in patients with active tuberculosis
but not in sarcoidosis patients. This was claimed to be
responsible for the lack of caseation in sarcoidosis. D. G. James
(London) said that the cardinal feature of depression of delayed-
type hypersensitivity was presumably due to immunological
bankruptcy of thymus-mediated lymphocytes. Although there
was hyporeactivity of these antibody-carrying lymphocytes,
circulating or serological antibodies were unimpaired. The other
characteristic feature of sarcoidosis was the formation of torpid
granulomas in all tissues and also in response to the intradermal
inoculation of human spleen sarcoid tissue.13
An important portion of the congress was devoted to
asthma. D. G. Wraith and K. Maunsell (London) reported that
a mite, Dermatophagoides, found in house dust was an im-
portant and widespread cause of respiratory allergy in Britain.
High concentrations of the mites were noted in bed mattresses
of all types, particularly if they were not regularly brushed
and aerated, also in bedroom ﬂoor dust, sacks, handkerchiefs,
and pockets. Intradermal skin tests with mite extracts were
positive in high dilutions. A. W. Frankland (London) also
drew attention to insect allergens, which could be inhaled
or injected by stings. Humans respond to mosquito bites by
the development of delayed- and immediate-type reactions,
both of which disappeared with desensitization. Locusts were
strong sensitizers causing asthma, particularly in those who
were constitutionally susceptible. He also warned of the dan-
gers of the grain weevil in wheat causing baker’s asthma and
bee stings causing acute anaphylaxis and sudden death.13
A. William Frankland also reviewed the many factors
responsible for asthma. Although asthma was inﬂuenced by
corticosteroids, allergic asthma was often unimproved during
pregnancy. He reiterated the possible danger of cardiac
arrhythmias and even sudden death due to the abuse of
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atomizers containing adrenaline. The potency of these bron-
chodilators was emphasized by D. Bates (Montreal); for
airways, obstruction was reversed, and the forced expiratory
volume improved within 2 breaths and was maximal within
20 minutes of using an aerosol. Iodine 125 administered by
inhalation and intravenous radioactive xenon were now being
applied to the study of respiratory function in asthma.
Ventilation was noted to be poor in the apices and bases of
the lungs of the asthma groups, whereas the maximal
abnormality was only at the lung bases of the chronic bronchitic
smoker. Bad zones of ventilation revealed arterial oxygen
tensions as low as 50 mm Hg mercury. Scans showed uneven
distribution, and the lung of the asthmatic patient adjusted its
perfusion to the abnormal ventilation. The overinﬂated lungs of
the asthma groups seemed to lose their elasticity temporarily.
There is also a syndrome in which bronchospasm did not
coincide with exercise but instead developed when the subject
was resting 4 minutes or so after exercise. Metabolic acidosis
led to a falling pH, which had a spastic effect on the pulmonary
circulation. The postexercise bronchospasm diminished or
disappeared with adrenaline or its analogs.13
In systemic lupus erythematosus, using the immuno-
ﬂuorescence technique to demonstrate circulating antinuclear
antibodies, J. T. Watson and his colleagues (Montreal) had
deﬁned 4 patterns of nuclear ﬂuorescent staining, with
different prognostic signiﬁcance. J. H. Vaughan (Rochester)
reported a series of 15 patients in whom the syndrome was
provoked by procainamide. Symptoms usually began after the
drug had been taken for several months. Eight months after
discontinuing the drug, most of the patients were asymptom-
atic. This improvement on withdrawal of the drug was one of
the distinguishing features from the idiopathic disease, the
others being absence of renal involvement and normal serum
complement levels.13
Samuel O. Freedman (Montreal) had prepared a tumor
antigen from carcinoma of the human colon and, by in-
oculation into rabbits, produced a speciﬁc antiserum. Similar
antigens could be made from embryonic gut, so that they
were collectively referred to as carcinoembryonic antigen. A
serological survey had shown that the speciﬁc circulating
antibody was always absent in normal people. It was,
however, present in 70% of patients with carcinomas of the
alimentary tract but absent in those with metastases, possibly
because circulating antibodies were absorbed by such a large
antigenic mass of cancer cells. The antibody was speciﬁc for
tumors of the digestive tract but also present in pregnancy
because of the presence of fetal material. One could also
demonstrate ﬂuorescence in antigen–antibody complexes in
human rectal cancer. Thus, it should be possible to stain feces
for the presence of tumor antigen.13
Author’s Personal Comments
The Montreal Congress was possibly the ﬁrst congress of
the IAACI where high North American scientiﬁc standards
were consequently applied, not only in the choice of guest
speakers but also in the selection of presented communications.
Up to that time, some local and “political” criteria had mixed
in, ending up in a heterogeneous bag in terms of scientiﬁc
quality. For me, this congress was one of the ﬁrst where the
whole scientiﬁc research in allergology and immunology, par-
ticularly from North America, was widely represented. The
congress was dominated by a towering ﬁgure, our host Bram
Rose, a most distinguished gentleman, combining charm, sci-
entiﬁc competence, and warm hospitality. This, together with
an efﬁcient organization, and the warmth of our Canadian
colleagues more than compensated for the freezing outside
temperatures. In 1967, a professional permanent executive sec-
retariat was established for the ﬁrst time in the person of
Suzanne K. Edwards, who had also been instrumental in orga-
nizing the Montreal Congress.
VII International Congress of Allergology,
Florence, 1970
At the time of the VII International Congress of
Allergology (Florence, 1970), the IAA counted 34 societies
with some 6000 members. The congress was held at the new
Palazzo dei Congressi from October 14 to 20, 1970, under the
presidency of Umberto Seraﬁni and with Mario Ricci as
secretary-general. It was attended by 1685 participants.16
The congress encompassed 7 invited lectures, 9 sympo-
sia, 1 panel, 1 roundtable, and 38 section meetings. Sixty guest
speakers from many different countries were invited.16,17
On the program were interesting symposia on immu-
noglobulins, antibodies, drug hypersensitivity, and asthma in
children. Several hundred free communications on various
topics in allergy were presented also.
Author’s Personal Comments
Florence was for IAA the congress of consolidation and
conﬁrmation as a professional organization. The permanent
secretariat assumed by Suzanne K. Edwards had functioned to
general satisfaction, even in ﬁnancial terms, and was
reconducted enthusiastically. The working program was
somewhat more devoted to the core of allergy than the
preceding congresses, reﬂecting perhaps the emergence in the
same year of an IUIS, of which I was the ﬁrst secretary-
general. Close cooperation between the 2 professional
organizations was planned from the start.
Florence, 1970, was for me some surprise because as
a young chick of 42 and only attending my third congress, I
was elected as second vice president, a clear breach in the
IAA tradition and procedures, which had been very restrictive
until then and most attentive to seniority principles. That
breach according to the minutes was initiated involuntarily by
the Nominating Committee, which had proposed 2 Mexicans,
certainly one too many from the same region. The Executive
Committee corrected the mishap by putting me up for
nomination, ﬁrst as member-at-large and then as second vice
president, instead of Jack Pepys. It is certainly the only time
that I caused such an affront, unwillingly, to my old friend
Jack. This was to be the start of a 30-year career in the IAA
Executive Committee.
VIII International Congress of Allergology,
Tokyo, 1973
The VIII International Congress of Allergology was
held at the hotel New Otani in Tokyo from October 14 to 20,
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1973, under the local chairmanship of Y. Oshima, Y. Kimura,
and N. Kobayashi (Fig. 3). As the IAA president, Max Samter
established a forceful leadership. The congress was attended
by some 1760 participants from more than 50 countries.17
It deﬁnitely established allergology as a discipline in
medical science, far away from the pragmatic witchcraft of the
past, as it was still seen by many physicians. The congress
presented 5 plenary morning sessions on reaginic antibodies in
disease, lymphocytes in regulation of immunological responses,
cellular hypersensitivity in the pathogenesis of immunological
disease, biochemical regulations, and pharmacological control
of tissue reactions and posed unanswered questions in allergy
and some possible answers. To this were added afternoon
sessions on bronchial asthma, drug allergy, the immunology of
vasculitis, and animal models of immunological reactions, as
well as more than 400 free communications.5,18
Author’s Personal Comments
The eighth congress was the ﬁrst to be held in Japan and
was the opportunity for many colleagues to become really
acquainted with a community of allergologists who had
remained somewhat isolated for a long time and with a country
and culture that were to play a major role in the past 3 decades
of the 20th century. At the time, Japan was still pretty insular; it
was difﬁcult to ﬁnd a taxi driver speaking English. You had
better carry on you a postcard from your hotel to make sure
you would ﬁnd your way back to your hotel room after an
excursion in town. The organization was perfect but very rigid;
any changes in the program requested because some people
were on duty at 2 different places simultaneously were
systematically refused. Only our President Max Samter had
the charm to navigate freely among the ceremonials.
IX International Congress of Allergology,
Buenos Aires, 1976
The IX International Congress of Allergology was held
at the Sheraton Hotel in Buenos Aires from October 24 to 30,
1976, under Enrique Mathov as chairman of the Organizing
Committee.19 The congress occurred under difﬁcult circum-
stances because the government of Isabel Martinez de Peron
had been forcibly replaced by a military junta a few months
before, with many economic and security problems. For that
reason, many delegates and guest speakers canceled their
attendance, sometimes at the last moment. The number of
delegates was nevertheless about 1300.5,19
Full sessions were held on advances in immediate-type
allergy (H. Bennich, K. Ishizaka, A. H. Sehon, T. Tada,
H. Bazin, L. M. and Lichtenstein), advances in cancer
immunology (G. Klein, P. Alexander, G. A. Voisin, and
G. Mathé), advances in cellular immunology (K. Rajewsky,
H. Wigzell, B. Bloom, A. L. de Weck, and B. Cinader), clinical
aspects of bronchial asthma (D. B. Amos, M. J. Dulfano,
C. E. Reed, A. Roncoroni, J. M. Dubois de Montreynaud,
and F. Lahoz), regional problems in bronchial asthma and
complement in allergic diseases (M. Mayer, I. H. Lepow,
A. Dalmasso, I. Gigli, V. Nussenzweig, and K. Nishioka),
dermatological allergy (I. Juhlin, E. Macher, E. Schöpf,
N. Soter, and L. Polak), advances in clinical immunology
(A. C. Allison, P. Hesnon, R. A. Good, O. van Bekkum, and
N. F. Mendes), advances in allergen chemistry (L. Goodfriend,
A. Malley, B. Brighton, J. L. Longbottom, T. Miyamoto,
and G. Gleich), new diagnostic procedures in allergy
(C. Arbesman, R. P. Siraganian, J. Brostoff, J. P. Girard, and
J. Bacigaluppi), mediators of immediate-type allergy
(H. Metzger, S. I. Wasserman, K. F. Austen, P. Piper, and J.
Benveniste), evaluation of new drugs in allergy (I. Glazer, M.
Grinstein, P. Naranjo, E. S. Assem, and D. N. Shivpuri), and
interstitial pneumopathies and occupational asthma (J. Salvag-
gio, A. Palma-Carlos, J. Pepys, and A. W. Frankland). In
addition, 358 free communications were presented.19
Author’s Personal Comments
The ninth congress in Argentina was placed from the
start under a difﬁcult shadow. The ﬁrst was the personality of
its president, Dr Mathov, an allergologist of high repute in
FIGURE 3. Ofﬁcial logo of the VIII International Congress of
Allergology, Tokyo, 1973.
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Argentina and Latin America but not very well acquainted
with other parts of the allergological world. This made him
not optimally prepared for the international tasks that awaited
him. Two preparatory and preliminary trips by the IAA
ofﬁcers to Argentina in 1974 and 1975 did not quite sufﬁce to
compensate for the authoritarian and sometimes autistic
handling of the matters at the local level. In addition,
the military revolution and the deposition of the Argentine
President Isabel Martinez de Peron, a few months before the
congress, created a climate of insecurity and fear that were
little conducive to congress activities, which were held under
heavy-armed guard. As a result, numerous North American
delegates stayed away at the last moment.
As a result, the congress suffered for the ﬁrst time in its
history a heavy ﬁnancial loss, of about $36,000, which almost
broke its ﬁnancial back. As treasurer, and in the absence of
our permanent secretary who was ill, I was practically left
alone to mend the broken pieces, an ordeal that I have
depicted in my memoirs. Nevertheless, the warm hospitality
of our Argentine friends and the numerous ﬁestas compen-
sated somehow for the administrative mishaps.
X International Congress of Allergology,
Jerusalem, 1979
The X International Congress of Allergology took place
in Jerusalem at the Hilton Hotel from November 4 to 11, 1979
(Fig. 4). It was organized by Israel Glazer and Nathan Lass as
cochairmen of the Organizing Committee and Edgar Pick as
secretary-general and Israel A. Pick as treasurer. The congress
was attended by about 1700 delegates from 35 countries. One
signiﬁcant move at that congress was the approval of a change
of name: The IAA became the IAACI.
The congress in Jerusalem was, although somewhat
smaller than the preceding ones, very successful. It particu-
larly facilitated the integration of the very active and vivid
immunological communities of Israel, with its universities
and the world-renowned Weizmann Institute of Science.
Eleven symposia were devoted to the following:
• recent advances in immunology (with contributions by
M. Sela, M. Feldman, A. L. de Weck, N. Trainin, and
K. Ishizaka);
• new perspectives in regulation of the IgE response
(T. Kishimoto, D. H. Katz, A. Sehon, C. R. Zeiss, and
K. Ishizaka);
• allergy in otorhinolaryngology (P. van Cauwenberghe,
T. Ishii, J. T. Connell, H. Mygind, R. E. Reisman,
M. Okuda, T. A. E. Platts-Mills, and I. M. Bernstein);
• immunological and pharmacological mechanisms in
allergy (T. Ishizaka, B. Diamant, L. M. Lichtenstein,
W. W. Brocklehurst, A. Szczeklik, and S. Wasserman)
(A. B. Kay, H. F. Dvorak, O. Strannegard, J. Bienenstock,
B. Zweiman, and K. F. Austen);
• immunology of parasitosis (H. C. Goodman,
K. Ishjizaka, R. A. Binaghi, A. Capron, A. E. Butterworth,
and K. J. Turner);
• bronchial asthma (G. Schultz, M. A. Kaliner, A. P. Kaplan,
A. Szentivanyi, J. A. Nadel, S. Godfrey, and E. Ellis);
• effect of experimental and occupational agents on the lung
and its bronchial airways (R. G. Slavin, J. Salvaggio,
K. Aas, M. Young, J. N. Fink, A. J. Newmanà Taylor,
J. Pepys, and K. Alanko);
• biological rhythms in allergy and immunology (J. P.
McGovern, N. R. Hetzel, F. Caradente, G. Fernandez,
G. Gaultier, P. Gervais, S. Bonini, M. Knapp, H. von
Mayersbach, J. D. Fitzgerald, and M. J. Rosenbaum);
• cell-mediated reactions (A. L. de Weck, C. Sorg, and
E. Pick);
• untoward reactions to insects (I. S. Ishay, H. E. Reisman,
L. M. Lichtenstein, A. Grant, R. F. Lockey, J. Croce,
T. King, and T. Miyamoto).20
In addition, more than 400 free communications were
presented.20
Author’s Personal Comments
The X congress in Israel took place in a cheerful mood.
After the 1967 and 1973 wars, the State of Israel seemed
secure and well installed in new borders, particularly in the
Old City of Jerusalem, which was a big attraction for IAACI
delegates. The State of Israel was also particularly attentive to
the congress and delegated its President Yitzhak Navon.
There was some hope that the wounds suffered by the
FIGURE 4. Cover of the ﬁnal program of the X International
Congress of Allergology, Jerusalem, 1979.
WAO Journal  November 2011 First 50 Years of IAA/IAACI/WAO
 2011 World Allergy Organization 209
Palestinian and Arab peoples would also be mended with
time. On a more modest scale, the IAACI treasury had also
somewhat recovered from the Argentine congress debacle 3
years earlier. So, everything looked for the best.
Paradoxically, although the IAA had added Clinical
Immunology to its name, the content of the congress signaled
some return to original allergological themes. Basic immu-
nology, clinical immunology, and transplantation were at the
time taken over by new speciﬁc international organizations
actively developing, such as the IUIS and the Transplantation
Society.
XI International Congress of Allergology
and Clinical Immunology, London, 1982
The XI International Congress of Allergology and
Clinical Immunology took place at the Barbican Centre in
London from October 17 to 22, 1982. The patron of the
congress was Her Majesty Queen Elizabeth II. Jack Pepys
was chairman of the Organizing Committee and Robert
Davies was cochairman. A shadow was brought by the
untimely death of Carl Arbesman, the IAACI president,
a few weeks before the congress. According to the IAACI
constitution, he was replaced temporarily by Alain de Weck,
ﬁrst vice president. The congress was attended by approxi-
mately 2000 delegates from 57 countries.21,22
The congress program encompassed 20 symposia on
topics such as mediators of allergic tissue reactions
(K. F. Austen, L. M. Lichtenstein, T. Ishizaka, B. Samuelsson,
S. I. Wasserman, R. N. Pinckard, R. P. Siraganian, and
A. P. Kaplan), reactions to drugs (H. D. Schlumberger,
N. F. Adkinson, P. L. Lieberman, J. Charpin, and P. Girard),
ﬁbrosing alveolitis (J. E. Salvaggio, M. Turner-Warwick,
C. Molina, J. N. Fink, and T. Kawai), pediatric allergy with
neonatal and antenatal factors (J. F. Soothill, F. B. Michel,
B. Björksten, F. Björksten, and D. C. Heiner), dermatological
allergy (T. Provost, S. G. O. Johannsson, P. Askenaze,
R. C. Cormane, A. L. Sheffer, M. W. Greaves, and
W. E. Parish), food allergy (R. Paganelli, E. Lebenthal,
D. M. Moneret-Vautrin, S. A. Bock, and K. J. Bloch), diag-
nostic procedures in allergy (N. Mygind, R. J. Davies,
T. G. Merrett, T. A. E. Platts-Mills, R. P. Siraganian,
J. L. Longbottom, and C. R. Zeiss), cell membrane pharmaco-
logical receptors (J. C. Venter, M. A. Kaliner, R. Townley,
C. Dollery, and A. Szentivanyi), cell membrane antibody
receptors (A. B. Kay, A. Froese, H. L. Piegelberg, and
M. M. Frank), update on antiallergic drugs (E. R. McFadden,
M. Turner-Warwick, P. J. Pier, R. E. C. Altounyan, and
K. F. Austen), immunological approaches to the treatment
of allergy (R. Urbanek, L. M. Lichtenstein, R. J. Davies,
J. Dewdney, and A. L. de Weck), asthma research
(M. A. Kaliner, B. P. Richardson, A. Szentivanyi, M. Debelic,
and H. Herzog), clinical and experimental implications of long-
term (IgE) and short-term (IgG-STS) antibodies (W. E. Parish,
D. R. Stanworth, M. C. Conroy, L. Perelmutter, and
R. B. Moss), regulation of the IgE response (A. Sehon,
K. Ishizaka, A. L. de Weck, D. H. Katz, and T. Kishimoto),
respiratory tract hyperreactivity (D. W. Empey, S. Godfrey,
F. E. Hargreave, J. Orenek, E. R. McFadden, and T. H. Lee),
occupational respiratory allergy (H. Keskinen, R. Patterson,
I. L. Bernstein, A. Sosman, P. S. Burge, and H. Thiel), animal
and insect allergy (R. Rudolph, A. J. Newman-Taylor,
I. Litsky, J. L. Ohman, R. E. Reisman, and A. B. Kay),
role of lymphocytes in allergic reactions (M. Ricci,
D. C. Dumonde, E. Pick, H. N. Claman, F. S. Kantor, and
J. Turk), allergens (J. L. Logbottom, M. D. Chapman,
J. W. Yunginger, R. D. Tee, H. Löwenstein, and T. P. King),
and pharmacokinetics of antiallergic drugs (J. Morley, J. Cad-
well, E. F. Ellis, K. Brown, S. M. Harding, and E. Middleton).
No less than 58 parallel sessions were held, in addition to
a vast poster and industry exhibition.21 The social program
was also quite brilliant with a governmental reception at the
Lancaster House, a concert by the London Symphony
Orchestra and the HM Royal Marine Band, a formal banquet
in the Great Hall of St. Bartholomew’s Hospital, and an
Elizabethan feast at the Hatﬁeld House, as well as a farewell
dinner in the 1784 Porter Tun Room at the Whitbread Brewery.
Author’s Personal Comments
The start of the London Congress was saddened by the
unexpected death of Carl Arbesman, the IAACI president,
a few weeks before. I had, therefore, as ﬁrst vice president, to
take over as acting president all his formal duties at the
congress, while Jack Pepys performed as president of the
Organizing Committee and as president-elect. There were
many duties to perform, for which I had little time to prepare.
In addition, we experienced there the collapse of our
executive secretariat, R. W. Neal, who had replaced Suzanne
K. Edwards in 1979 and had delivered a very poor
performance. He was therefore replaced on short notice by
R. O’Neil, director of the Executive Director Inc (EDI) ofﬁce
in Milwaukee, who remained the executive secretariat of the
IAACI for the next 28 years (see sections on Executive Sec-
retariat and Finances).
Beyond the scientiﬁc program, which was excellent, I
have 3 anecdotic memories of that congress. The ﬁrst was that
the Barbican Centre was at the time quite new and lacked
some indicators for directions. For many delegates, it looked
more like a labyrinth than a congress hall; some claimed that
a few delegates got lost for the whole week. Another more
bright remembrance was a sumptuous formal dinner at the
Great Hall of St. Bartholomew’s Hospital. I sat there with my
wife at the side of the presiding host, the Duke of Gloucester,
a cousin of Her Majesty Queen Elizabeth II. I was particularly
impressed by the efﬁciency of his adjutant major, who had
prepared a minute-by-minute schedule of the event, including
a 5-minute recess for the Duke to go to the “loo” (as the
British say). Finally, I remember my disappointment when
the IAACI House of Delegates chose Cannes (France) by 1
vote over Montreux (Switzerland), which I had proposed for
the XIII ICACI congress 6 years later.
XII International Congress of Allergology
and Clinical Immunology, Washington,
DC, 1985
The XII International Congress of Allergology and
Clinical Immunology was held at the Sheraton Washington
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Hotel in Washington, DC, United States, from October 20 to
25, 1985. The Organizing Committee was chaired by Jack
Pepys and cochaired by Gilbert Barkin and Robert Goldstein.
Joseph Bellanti was secretary. The congress was attended by
approximately 3000 delegates.23,24
Eleven plenary and concurrent symposia were held on
topics such as clinical and basic aspects of IgE antibody (A. S.
Fauci, A. Capron, N. J. M. Kjelman, K. Ishizaka, and D. H.
Katz), IgG subclass antibodies in allergic disease (P. H.
Lambert, J. Brostoff, W. J. Stevens, D. Stanworth, R. C.
Aalberse, G. M. Gwynn, and A. G. Bootello), advances in
drug allergy (N. F. Adkinson, D. Vervloet, H. E. Amos, J.
Ring, and D. D. Stevenson), cellular mechanisms in allergic
reactions (G. G. Gleich, W. E. Parish, M. Joseph, C. Sorg, E.
L. Reinherz, and P. W. Askenaze), heterogeneity and
pharmacological modulation of mast and basophil cells (S.
Freedman and T. Ishizaka), autoimmune mechanisms in
common allergic disorders (J. C. Venter, S. G. O. Johansson,
H. Spiegelberg, R. S. Geha, and J. Pepys), mechanisms and
pathophysiology of asthma (B. G. Simonsson, F. E. Har-
greave, T. A. E. Platts-Mills, S. Godfrey, C. Zanussi, J. Nadel,
and S. Durham), immediate-type allergydan update on medi-
ators (M. A. Kaliner, D. Metcalfe, A. B. Kay, K. F. Austen, J.
Benveniste, A. P. Kaplan, J. Foreman, B. Stadler, and M. M.
Frank), progress in immunopharmacology and immunother-
apy (L. Chedid, S. Orr, H. Metzher, H. Loewenstein, G. Bar-
kin, and R. Patterson), dermatological allergy (M. W. Greaves,
A. Lahti, S. I. Katz, I. Gigli, W. P. Jordan, and J. M. Haniﬁn),
the future of allergy (T. Waldman, A. L. de Weck, R. A.
Baldo, D. H. Katz, K. Ishizaka, S. Holgate, J. Pepys, and
M. A. Kaliner), food allergy (K. J. Bloch, M. H. Lessof, M.
Silverman, H. A. Sampson, R. N. Hamburger, D. Moneret-
Vautrin, and D. D. Metcalfe), and occupational respiratory
allergy (P. Gervais, J. E. Salvaggio, C. R. Zeiss, R. J. Davies,
and M. Chan-Yeung). In various abstract sessions, 428 free
communications were presented, as well as 736 posters. The
industry exhibition was set up by 43 exhibitors.23,24 The social
events encompassed a welcome reception at the Sheraton,
a concert by the National Symphony Orchestra at the Kennedy
Center, a giant barbecue on the mall, and a farewell dinner
dance at the Sheraton Washington Hotel.
Author’s Personal Comments
The congress in Washington, DC, had for me a special
ﬂavor because I was on sabbatical at the National Institutes of
Health in Washington, DC, during that year (1984–1985)
preceding the congress. I became therefore actively engaged
in its organization and privy to a number of quarrels behind
the scenes between the 2 national American IAACI member
societies [the American Academy of Allergy, Asthma and
Immunology (AAAAI) and the American College of Allergy,
Asthma and Immunology]. Most of the objects of these quar-
rels had more to do with personal differences than fundamen-
tal matters, and I have therefore not retained them for
historical purposes.
The congress was certainly a full scientiﬁc and social
success; it was attended by more than 3000 participants and
yielded a substantial income, deﬁnitely putting IAACI on
solid ﬁnancial footing after the Argentine congress debacle. It
also did a great deal to rekindle the interest of American
allergists for the international scene.
XIII International Congress of Allergology
and Clinical Immunology, Montreux, 1988
The XIII International Congress of Allergology and
Clinical Immunology was held at the Montreux Congress
Center and the Montreux Palace in Montreux, Switzerland,
from October 16 to 22, 1988 (Fig. 5). Alain de Weck was
chair of the Organizing Committee, with Professor Philippe
Frei as vice chair and Dr Werner Pichler as secretary. The
congress was attended by more than 5600 delegates, an all-
time record.5,25
The scientiﬁc program included more than 20 plenary
and parallel symposia on allergic and inﬂammatory reac-
tions: the cells (K. F. Austen, J. Bienenstock, M. Capron,
D. Gemsa, A. Capron, B. M. Stadler, and P. W. Askenaze),
the mediators (C. W. Parker, A. B. Kay, A. P. Kaplan, and
FIGURE 5. Final announcement of the XIII International
Congress of Allergology and Clinical Immunology, Montreux,
1988.
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C. P. Page), cell–mediator interactions (L. M. Lichtenstein,
G. Stingl, R. Crystal, J. M. Dayer, and A. J. Zuckerman),
allergy prevention (N. J. M. Kjellman), diagnostic proce-
dures (S. G. O. Johannsson, R. Aalberse, B. David,
A. Pécoud, and S. Ahlstedt), immunomodulation (P. Grob,
F. Aiuti, K. Bolla, R. Petrov, and J. A. Bellanti), allergy and
changing environment (A. I. Terr, T. Miyamoto, J. Charpin,
T. A. E. Platts-Mills, P. C. Frei, R. Simon, J. E. Salvaggio,
and B. Björksten), management of allergy in the 1990s
(F. B. Michel, M. A. Kaliner, S. Holgate, J. Bousquet,
J. F. O’Hanlon, M. Drouin, and E. Monroe), perspectives
in allergy and clinical immunology (R. Pauwels,
M. H. Schreier, R. A. Good, R. Levinsky, J. F. Borel, and
B. von Graffenried), molecular characteristics of allergens,
highlights in clinical immunology (T. Kishimoto, E. Gleich-
mann, H. Waldmann, H. Metzger, A. S. Fauci, M. Lotze,
G. Nossal, and A. L. de Weck), immunotherapy (R. Patterson,
P. S. Norman, U. Müller, R. Urbanek, J. Bousquet, and
R. Jarisch), retrovirus infections (A. Moretta, D. Klatzmann,
R. Kurth, W. Haseltine, A. Sehon, and M. Grieco), and
IgE-related peptides (H. Metzger, B. Helm, D. Vercelli,
H. Spiegelberg, D. Stanworth, and R. N. Hamburger). In
addition, 333 free communications and 1033 posters were
presented, as well as 41 industrial exhibits.25 The social pro-
gram included an opening reception highlighted by the Land-
wehr of Fribourg, a reputed Swiss marching band, a dinner
excursion to several famous Swiss castles including the
Chillon Castle, an afternoon excursion to the Swiss National
Circus Knie in Martigny, and a farewell dinner dance at the
Casino of Montreux.25
Author’s Personal Comments
The Montreux Congress was the one in which I was the
most directly involved since totally responsible for all
organizational aspects. A major decision before the ﬁnal
planning was to involve, beyond the usual IAACI executive
secretariat, no professional congress organization but to solve
all problems by ourselves. This gave to the whole organiza-
tion a kind of personal and family touch but was also
responsible for a sizable ﬁnancial surplus. It was certainly
the last entirely “homemade” IAACI congress.
The holding of the congress in Montreux was also some
kind of surprise because in fact Cannes had been chosen 6 years
before. However, for various reasons, Jacques Charpin
renounced the organization and Montreux became a natural
substitute. Personally, I applied the recipe for a good organiza-
tion leader, which I had learned many times before. Make
yourself free and never plan to have something speciﬁc to do
during the event itself. In this way, you will remain fully
available for any mishap and troubleshooting that will un-
avoidably occur during a large meeting. The problem is not
what you have foreseen but what you have not imagined
possible. Indeed, the very large and unexpected number of
delegates created multiple logistical problems behind the scenes.
Besides a well-balanced scientiﬁc program, 2 social
events have remained in the memory of the participants.
Dinner was served one evening in 7 medieval Swiss castles
within a 100-km circle from Montreux, which presented
a sizable transportation and logistical problem, to be solved
by military transportation techniques! The next day, 3 special
trains transported the whole congress to an afternoon circus
show. The whole was certainly the largest manifestation I ever
organized and was a potent occasion to reafﬁrm ties, not only
in my own surroundings but also with the whole IAACI family.
XIV International Congress of Allergology
and Clinical Immunology, Kyoto, 1991
The XIV International Congress of Allergology and
Clinical Immunology was held at the Kyoto International
Conference Hall in Kyoto, Japan, from October 13 to 18,
1991 (Fig. 6). Terumasa Miyamoto was chair of the Organiz-
ing Committee, M. Hanaoka and H. Mikawa were vice chairs,
and Y. Kimura was secretary-general. The congress was
attended by about 3000 delegates.26
Twenty-one plenary and concurrent symposia were
held on topics such as IgE synthesis and receptor interactions
(W. E. Paul, S. Romagnani, J. E. de Vries, K. Ishizaka,
H. Metzger, G. Delespesse, and A. Capron), recently devel-
oped antiallergic and related drugs (A. Koda, R. Pauwels,
S. T. Holgate, A. W. Ford-Hutchinson, W. Dorsch, and
R. P. Schleimer), house dust and mite allergy (T. A. E. Platts-
Mills, M. Sanchez-Medina, J. Croce, D. Vervloet,
H. Okudaira, M. D. Chapman, and U. Wahn), ophthalmic
allergy (S. Ohno, H. Mochizuki, S. Bonini, R. J. Buckley,
K. F. Tabarra, and L. M. T. Collum), occupational
and environmental allergy, diagnosis and monitoring of
allergic diseases (S. G. O. Johanssson, L. H. Schwartz,
L. M. Lichtenstein, A. L. de Weck, J. Bousquet,
H. A. Sampson, and S. Croner), the role of PAF and the
importance of PAF antagonists in respiratory diseases
(P. Braquet, P. J. Barnes, S. Makino, B. B. Vargaftig,
P. M. O’Byrne, and H. Heuer), perspectives in food allergy
(C. Andre, D. D. Metcalfe, L. Businco, M. Baba, M. Sanchez-
Borges, and B. Wühtrich), mediator release and its modula-
tion (K. F. Austen, R. P. Siraganian, D. Kennerly, S. Kohno,
A. P. Kaplan, D. MacGlashan, and G. Marone). New con-
cepts in clinical immunology (B. Pernis, T. Shimi,
S. F. Schlossman, J. L. Fahey, I. M. Roitt, R. S. Geha, and
K. Kobayashi), inﬂammatory cells and cytokines in allergy
(A. B. Kay, G. J. Gleich, J. J. Oppenheim, C. Dahinden,
K. Takatsu, T. Kishimoto, and K. Arai), mast cells and baso-
phils (Y. Kitamura, A. M. Dvorak, T. Ishizaka, J. Bienenstock,
M. K. Church, and J. A. Denburg), pathogenesis and treat-
ment of collagen diseases (R. N. Maini, P. E. Lipsky,
E. M. Tan, N. Talal, R. C. Williams, and T. Abe), derma-
toimmunology (J. Thivolet, T. A. Luger, R. F. Tigelaar,
J. Ring, H. Yoshida, and J. C. Byrstyn), impact of biotechnol-
ogy on allergy research (H. A. Helm, J. P. Kinet, J. Oksenberg,
W. R. Thomas, B. M. Stadler, R. Arnon, D. R. Stanworth, and
A. H. Sehon), pathogenesis and treatment of bronchial asthma
(F. E. Hargreave, M. A. Kaliner, J. Morley, A. Oehling,
W. Busse, R. Patterson, and F. B. Michel), improving the
quality of life in asthma (T. Miyamoto, M. A. Kaliner,
R. Pauwels, T. H. Lee, G. S. Rachelefsky, S. T. Holgate,
and S. Makino), pediatric allergy (O. L. Frick, R. H. Buckley,
M. Tischinda, E. F. Ellis, K. G. Sohn, K. Faith-Magnusson,
and J. Anderson), physical allergy (M. Ichibashi, L. Greiding,
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S. Wasserman, A. L. Sheffer, and W. E. Pierson), epidemiology
and genetics of allergic diseases (K. H. Hsieh, A. Woodcock,
B. Björksten, D. Charpin, R. A. Goldstein, T. Takahashi, and
T. J. H. Clark), pathophysiology and management of nasal
congestion (M. Okuida, P. van Cauwenberge, P. H. Howarth,
A. R. Pécoud, and J. A. Grant).26
In addition, 581 free communications and 1164 posters
were presented. The industry exhibition included 45 exhib-
itors.26 The social events included a welcome reception at the
Kyoto Main Hall, a quartet concert, a half-day excursion to
various temples and Otsu Lake, a Noh theater representation,
and a gala reception at the Miyako Hotel.26
Author’s Personal Comments
The XIV congress was the second IAACI congress
organized in Japan in 18 years. By that time, I had become
very familiar with that country, which had sent many
postdoctoral fellows over the years to my institute in
Switzerland. It was therefore a kind of home visit.
The Kyoto setup was particularly conducive to conviv-
ial exchanges of thoughts and friendships. As usual, the
organization was perfect, and we also had the opportunity to
appreciate various aspects of Japanese culture such as
a brilliant reception in ofﬁcial gardens and a Noh play.
From a scientiﬁc point of view, the new generation of
allergologists and immunologists in Japan was very much in
evidence. Insular isolation was deﬁnitely broken, and the
pioneering role of Japanese allergy research was increasingly
recognized.
XV International Congress of Allergology
and Clinical Immunology, Stockholm, 1994
The XV International Congress of Allergology and
Clinical Immunology was held at the Stockholm Congress
Center in Stockholm from June 20 to 26, 1994, together with
the annual congress of the European Academy of Allergy and
Clinical Immunology (EAACI). This provided for the largest
allergy congress ever, with more than 6000 participants. The
IAACI congress was organized by S. Gunnar Johansson as
president of the local Organizing Committee.27
The main symposia had the following themes: high-risk
asthmatic groups, identiﬁcation and care, clinical use of clonal
peptides, occupational allergy, 15 years with leukotrienes, IgE
as a model for immunoregulation, epidemiology, the impact of
science on allergy and immunology, cell-to-cell interactions in
allergy, the genetic basis for atopy, the role of auto-anti-IgE
antibodies, hypersensitivity reactions to drugs, and education
and training of allergic and asthmatic patients.27 Plenary ses-
sions were on recent advances in mechanisms of allergy, new
concepts in the understanding of asthma, basic immunology in
relation to the development of allergy, environmental impact
on hypersensitivity and allergy, new approaches to treatment of
allergy, asthma, and hyperreactivity.27
Author’s Personal Comments
Because the ICACI merged for the occasion with the
annual meeting of the European Academy, it provided for the
largest allergy congress ever held. Nevertheless, the organi-
zation was ﬂawless and the usual blend of scientiﬁc and social
activities went well. Together with a beautiful season, many
aspects of the Stockholm archipelago contributed to create
a holiday ﬂavor.
Particularly memorable for me was the gala dinner in the
court of the Town Hall where a standing ovation greeted my
old friend Jack Pepys, celebrating his 80th birthday. This seems
to have been his last public appearance at a large meeting.
XVI International Congress of Allergology
and Clinical Immunology, Cancun, October
19 to 24, 1997
The XVI International Congress of Allergology and
Clinical Immunology was held in the Congress Center of
Cancun (Mexico) from October 19 to 24 under the presidency
of A. Oehling and J. C. Huerta-Lopez (Fig. 7). It was well
attended by North American participants and gathered a total
of more than 4000 delegates. The congress was well spon-
sored and became a huge ﬁnancial success for IAACI.28
The main symposia were on cytokines and chemokines in
allergic diseases, advances in atopic dermatitis, cell receptors
and adhesion molecules in hypersensitivity, in vitro diagnosis
of allergic diseases, IgE synthesis regulating factors and
receptors, dynamics and immunopathology of food allergy,
FIGURE 6. Ofﬁcial logo of the XIV International Congress of
Allergology and Clinical Immunology, Kyoto, 1991.
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immunotherapy, genetic basis of allergy, and allergic diseases
in Latin America.28
Parallel symposia were held on development and
maturation of mast cells, basophils, and eosinophils; antige-
nicity and structure of inhalant and food allergens; and allergic
diseases in gastroenterology: mucosal immunity, immuno-
logical mechanisms in urticaria, immunological mechanisms
in contact dermatitis, neonatal and perinatal factors of asthma
and allergic diseases, allergic rhinitis and sinusitis, asthma and
infection, intrinsic asthma, recent advances in asthma therapy,
neurogenic inﬂammation and allergy, occupational bron-
chial asthma, environmental pollutants and allergic diseases,
lung function procedures in bronchial asthma, immunodeﬁ-
ciency diseases, allergic diseases in infancy, autoimmune skin
diseases, immunopathology of drug allergy, advances in
immunopathology of bronchial asthma, ocular allergies, and
immunopathology of autoimmune diseases.28
Author’s Personal Comments
The XIV IAACI congress had ﬁrst been scheduled to
take place in Mexico City, but for various logistical and
security reasons, it was decided on rather short notice to
displace it to Cancun, on the eastern tip of the Yucatan
Peninsula. In that congress, the local and logistical organization
was also taken over to a large extent directly by our EDI, which
managed a huge success, handling with tact some issues
relating to administrative efﬁciency and local susceptibilities. It
was also the last IAACI congress in which I was personally
involved in terms of planning and scientiﬁc program advisor. If
Cancun has very little Mexican ﬂavor, the facilities, the sea,
FIGURE 7. Cover of the ﬁnal
program of the XVI International
Congress of Allergology and Clinical
Immunology, Cancun, 1997.
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and the beach contributed to create a pleasant atmosphere and
nevertheless a suitable environment for work.
MEMBER SOCIETIES
Historical Development of Membership
Before the foundation of the IAA in 1951, only a few
national allergy societies existed or had an existence of more
than a few years. These “historical” societies and founding
members of IAA included the following:
• The American Academy of Allergy
• The American College of Allergists
• The American Society of Ophthalmologic and Otolar-
yngologic Allergy
• Asociación Argentina de Alergia e Inmunologia
• Sociedad Argentina de Alergia
• Section on Allergy, Australia
• Société Belge de l’ Allergie
• Sociedade Brasileira de Alergia
• British Association of Allergists
• Canadian Academy of Allergy
• Sociedad Chilena de Alergia
• Sociedad Colombiana de Alergia
• Sociedad Cubana de Alergia
• Danish Society for Allergological Research
• Deutsche Gesellschaft für Allergie-Forschung
• Sociedad Española de Alergia
• Finnish Allergy Society
• Hungarian Society of Allergists
• The Israel Society of Allergy
• Associazione Italiana per lo Studio dell’Allergia
• Japanese Society of Allergology
• Sociedad Mexicana de Alergistas
• Nederlandse Vereniging voor Allergie
• Sociedad Peruana de Alergia
• Sociedade Portuguesa de Alergia
• South-African Allergy Society
• Swedish Association of Allergists
• Schweizerische Allergie-Gesellschaft
• Sociedad Uruguaya de Alergia.
Quite a number of national societies were also founded
only around the time of the IAA beginnings, and it is difﬁcult
to assess which was the hen and which was the egg: a national
endeavor and/or the desire to participate in an international
movement. Many of the new societies were the initiative of
only a few men, who were understandably seeking recogni-
tion for a new specialty and for themselves in a rather
traditional medical world.
The IAA counted then 29 member societies, originating
from Europe (13), North America (3), Latin America (8), Asia
(2), and Africa (1). The high density of national allergy societies
in Latin America at the beginning is rather striking, but as the
records and membership lists show, the seeds were rather thin
and only bore real fruits several decades later. In addition, we
assisted to a phenomenon speciﬁc to Latin America and its
sometimes agitated political customs: several national societies
split to accommodate conﬂicting personalities as presidents and
would-be presidents. The utmost was Argentina, which claimed
at some time up to 4 separate allergy societies.
A historical summary of all IAACI member societies is
given in Table 2 and follows the entire evolution. During the
ﬁrst 30 years, membership seems to have remained rather
stable because only 4 additions (India, Norway, Philippines,
and Yugoslavia) were added to the original list.
Between 1980 and 2000, however, numerous countries
created a new national allergy society, which sooner or later
joined the IAACI. The admission procedure was by then well
established, and the conditions for admission were well
deﬁned. If all duplicate or triplicate national societies could
not be melted into one, mostly for historical reasons, the trend
was nevertheless to admit only truly representative and viable
groups. The trend has obviously continued in the last decade
(2000–2010), which has seen the admission of about 10 new
national societies. At the same time, a number of the original
IAA societies had disappeared from the map or were down-
graded to the status of associate member (without voting
rights), mostly because of lack of activity or failure to pay
dues. The evolution of allergy in various countries of the
world has been very variable. In some countries like Japan,
the growth in membership has been explosive; in others,
particularly in Latin America and in some European coun-
tries, it has been rather stable. In all, the IAACI counted in
1999 more than 21,500 dues-paying members and made it
clearly the largest allergy organization in the world.
An additional phenomenon of the allergy world, partic-
ularly since the 1980s, has been the admission as regional
organizations of large and active regional groups, such as the
Asia Paciﬁc Association of Allergy, Asthma and Clinical
Immunology, the EAACI, the Latin American Society of
Allergy, Asthma and Immunology, and the Commonwealth of
Independent States Society of Immunology and Allergology.
In addition, the IAACI, now the WAO, entertains relationships
with a variety of afﬁliate organizations, such as GA2LEN
(Global Allergy and Asthma European Network) and INTER-
ASMA. In this way and at this time, it can really be said that
the old IAA, now under the name of WAO, has truly become
representative of the allergy ﬁeld all over the world.
Major Allergy Societies
It cannot be the ambition of this historical document to
trace the history of all national allergy society members of the
IAA/IAACI/WAO. However, because some of these societies
have a very interesting history of their own and represent true
pillars in the ﬁeld, I feel it useful to provide a few links to
where available to historical information outlining the history
of allergy in some major countries.
• AAAAI (http://www.aaaai.org/about-the-aaaai/history.aspx)
• American College of Allergy, Asthma and Immunology
• British Society for Allergy and Clinical Immunology
(http://www.bsaci.org/index.php?option¼com content
&task¼view&id¼12&Itemid¼27)
• French Society of Allergology
• German Society of Allergy (now the German Society for
Allergology and Clinical Immunology) (http://dgaki.de/
archiv/)
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• Netherlands Society of Allergology
• Russian Association of Allergology and Clinical
Immunology
• Austrian Society of Allergology and Immunology
• Swiss Society for Allergology and Immunology
• EAACI (http://www.eaaci.net/organization)
• Italian Society of Allergology and Clinical Immunology
• Spanish Society of Allergology and Clinical
Immunology.
This list is obviously incomplete, and the documentation
could be improved on by the member societies themselves.
EXECUTIVE COMMITTEE AND OFFICERS
The soul of any formal association is constituted by its
presidents and its ofﬁcers. From their qualities and perfor-
mance, the whole association depends and sometimes, as is
the case here, the establishment and recognition of a new
discipline. In this respect, historical notes about the men who
have directed the IAA/IAACI over the years are of greater
interest to the history of allergy than mere reports about
meetings and congresses, as above. Biographic eulogies have
a tendency to glorify the subject; personal reminiscences are
often biased. I shall therefore offer to the interested reader
a little bit of both.
Meetings and Functions of the
Executive Committee
The initial Constitution and Bylaws of IAA had fore-
seen an Executive Committee composed of a president,
a secretary-general, and a treasurer as ofﬁcers and 3 vice
presidents plus 5 to 7 members-at-large supposed to be
representative of the various regions of the world. This
structure remained essentially unchanged for the next 50
years (also see section on Constitution and Bylaws Commit-
tee). Renewal of the Executive Committee was affected by
elections triennially by the House of Delegates; maximal
terms of ofﬁce were foreseen only for the president and the
vice presidents (3 years) and the members-at-large (6 years)
but not for the secretary-general or the treasurer.
A summary of all members of the Executive Committee
during the years 1951 to 2010 is shown in Table 3. This
constitution and mode of operation guaranteed stability of
the organization but provided also for some inbreeding, in
that a relatively small number of individuals were in charge
of conducting the business. In the ﬁrst 20 years, this effect
was even reinforced by the fact that the Executive Committee
was meeting only once every 3 years, at the time of the tri-
ennial IAACI congress. This left in fact the whole power of
handling and representation in the hands of the president and
the secretary-general. This did not matter very much as long
as practically the sole business of the IAACI was to organize
congresses every third year. The limited ﬁnances anyway did
not allow for meetings of ofﬁcers or of the Executive Com-
mittee in between; most IAA business had therefore to be
expedited by correspondence.
From the 1980s on, the start of various permanent
activities (eg, standardization, education) and the improving
state of the ﬁnances enticed the Executive Committee to meet
more often. The fact that the annual meeting of the AAAAI
was increasingly attracting international leaders in the ﬁeld
facilitated matters, provided the opportunity to meet there.
Around the end of the 1990s, together with the impending
reform of IAACI and permanent worldwide activities within
the frame of the WAO, special meetings of the Executive
Committee became even more frequent. Schedules and
protocols of such meetings are available since 1970 (Table 4).
The detailed protocols of the Executive Committee meetings,
kept in the IAACI archives, provide the most complete and
detailed information about the activities of IAACI.
The House of Delegates
The House of Delegates, according to the original IAA
constitution, represents the parliament of the association and
is constituted of representatives nominated by the national
member societies. The number of ofﬁcial delegates from each
society is representative of their size (up to 1991: 1 delegate
for up to 300 members, 2 delegates above 300 members; after
1991: 3 delegates above 1000 members). The House of
Delegates met triennially at the occasion of the IAACI
congress, now biennially at the World Allergy Congress.
The major businesses of the House of Delegates are
to formally approve the handling of IAACI affairs by the
Executive Committee, which seldom gives matter to serious
debate, and to elect the Executive Committee and the ofﬁcers
based on a list of nominees provided by the Nominating
Committee and approved by the Executive Committee. This
list was usually approved globally and without debate. The
only political hot debate in the House of Delegates was
usually to select the location of the next IAACI congress,
based on several candidate proposals and increasingly pro-
fessional presentations, a little like the choice of the Olympic
Games. At the beginning, the choice was traditionally limited
to the country of residence of the acting IAACI president, but
this tradition has been broken since the early 1990s, often for
logistical, economic, and geographical distribution reasons.
The Presidents: Biographies and
Personal Reminiscences
During the ﬁrst 50 years, IAA/IAACI presidents have
mostly corresponded to the same proﬁle: an academically
active research scientist known at the international level,
a clinical and teaching leader, and the head of an institution
or a department providing education in allergy, leaving thereby
a lasting school of pupils and future leaders. In addition, the
function of president lasting 3 years and being preceded by at
least 3 other years as vice president or president-elect, the
presidency was of sufﬁcient duration to ensure continuity and
leave a mark. This is, in my eyes and experience, the main
reason why the IAACI has been successful. Of course, under
such circumstances, the choice of a president with professional
and international standing and experience becomes crucial.
The various IAA/IAACI presidents from 1951 to 2010
are listed in Table 5. Below are some biographical personal
notes particularly concerning those with whom I have been
de Weck WAO Journal  November 2011
216  2011 World Allergy Organization
personally acquainted, but these personal notes are limited up
to the year 2000.
Frederick “Fred” W. Wittich (1885–1965)
Biographic information is available in the archives of
the AAAAI and Annals of Allergy (1965, volume 23, pages
163–164).
Bernard Halpern (1904–1978)
Bernard Halpern, originally from Russia, became soon
after World War II, together with Pasteur Valéry-Radot the
pioneer and leader of French allergology. At the head of his
own group, he developed an intense fundamental and clinical
research activity. In this way, he also became the teacher and
promoter of a whole generation of French leaders in allergol-
ogy and immunology. His work soon became internationally
known, hence his decisive commitment to IAACI in its early
years, with the organization of the III International Congress
of Allergology in Paris, 1958, and his presidency in 1961.
Samuel M. Feinberg (1895–1973)
Samuel Feinberg was for many years heading one of the
ﬁrst academic groups in the United States devoted to allergy
at the Northwestern University Medical School in Chicago.
He was also one of the major founding ﬁgures of the IAA and
remained an important pillar of the association during its ﬁrst
10 years (Fig. 8).
Carlos Jiménez Diaz (1898–1967)
Carlos Jimenez Diaz was a highly respected professor
of Pathology at the University of Madrid, who developed
broad scientiﬁc interests in allergy and immunology (Fig. 9).
He was at the time one of the most prominent in the Spanish-
speaking world, including Latin America, and was since the
beginning one of the most inﬂuent leaders in the young IAA,
which was crowned by the Madrid Congress in 1964. His
spiritual legacy is still felt in Spain (Fig. 9).
Bram Rose (1907–1995)
Bram Rose (information not available at time of
publication), whom I had the opportunity to meet for the
ﬁrst time at the 1967 congress in Montreal, was the model of
the highly distinguished British gentleman while conveying
the hospitality and warm openness of the Canadian. He was at
the time the uncontested leader of Canadian allergology and
led a department at the McGill University in Montreal, which
became a very productive school. He played a decisive role
not only in his own country but also in establishing for IAACI
the goals of scientiﬁc excellence.
Umberto Seraﬁni (1912)
In Italy, Umberto Seraﬁni played likewise a decisive
leading and seeding role in the establishment and develop-
ment of modern allergy and clinical immunology, ﬁrst in
Florence, then in Rome. His inﬂuence has lasted for decades,
TABLE 4. IAA/IAACI Executive Committee Meetings
Site Date Main Decisions
Montreal August 11, 1967 IAACI 6000 members
Florence October 15, 1970 Problems with Nomination Committeednew Environmental Committee
Tokyo October 19, 1973 Move to add Clinical Immunologydjoint standardization with IUIS
Buenos Aires August 10, 1976 d
New York March 27, 1977 Lessons from deﬁcit Buenos Aires
Jerusalem September 11, 1979 Name change Clinical Immunologydsupport standardization
Ottawa September 13, 1980 d
London October 17, 1982 Publication newsletter
Chicago April 03, 1984 d
New York March 18, 1985 d
Washington October 23, 1985 Change venue 1988 from Cannes to Montreux
Washington February 22, 1987 d
Montreux October 18, 1988 d
San Antonio December 03, 1989 IAACI tax 12% on registration fees congressesdrevised constitution
Berlin September 21, 1989 14,000 members; IAACI directory worldwide
Baltimore March 28, 1990 Perspectives of Allergy program
San Francisco May 03, 1991 d
Kyoto October 13, 1991 New constitution
Paris October 05, 1992 Appraisal of EDI congress responsibilities
Chicago March 14, 1993 Move 17th ICACI from Mexico City to Cancun
Anaheim May 03, 1994 Approval special education programs POA
Stockholm June 18, 1994 Deﬁnition of special educational programsdseminars and conference committee
Madrid June 25, 1995 Dues raised to 5 CHF
San Francisco March 16, 1996 Relationships with respiratory societies
New Orleans February 16, 1997 American College refusing increased dues
Stockholm August 30, 1998 Strategic planning toward Allergy World Organization
Orlando February 26, 1999 d
Brussels June 07, 1999 Change IAACI to WAOdprofoundly revised constitution
POA, Perspectives of Allergy; CHF, Swiss franc.
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and his pupils have formed the scientiﬁc backbone of the
country. He was personally a prince of the Renaissance, with
a great ﬂair for prestigious celebrations and receptions,
together with a very personal touch.
Max Samter (1908–1998)
Originally from Berlin, Max Samter immigrated to the
United States before World War II and soon became a leader
of American allergology. He retained, however, the charm and
the culture of the old Europe, as well as its diplomatic skills.
But he was also very open to new ideas, to young people, and
to a spirit of scientiﬁc excellence. He has probably been one of
the presidents, together with his wife Victoria, who has most
inﬂuenced the IAACI and has determined its course, directly
and indirectly, for more than 20 years (Fig. 10).
Tiuzi Sindo (1907)
Tiuzi Sindo (information not available at time of
publication) was the head of the Department of Allergology
at the Institute of Infectious Diseases at the University of
Tokyo when he was elected as the ﬁrst Japanese president of
the IAA, after the successful congress in Tokyo, 1973. While
well recognized in his country, Tiuzi Sindo was hardly known
on the international scene and in former IAACI executive
circles. This made it quite difﬁcult for him to leave a real
mark in ofﬁce, despite his kind and consensual nature.
Enrique Mathov
At the time of his election as president of the IAACI,
Enrique Mathov (information not available at time of
publication) was a recognized leader of allergology not only
in Argentina but also in wider Latin American circles. He had
been a pioneer in teaching of allergy and clinical immunol-
ogy. Due to his Russian origin, he differed, however,
considerably in appearance and also in spirit from the usual
Latin American phenotype. As with his predecessor, he had
little acquaintance with the broader international allergy and
IAACI scene. Together with a rather authoritarian character
and the ﬁnancial ﬁasco of the congress in Buenos Aires in
1976, these added factors soon led to various conﬂicts within
the IAACI Executive Committee, which were only really
solved after his 3-year presidency period.
Carl Arbesman (1911–1982)
As the head of the Allergy Laboratory at the Buffalo
General Hospital in Buffalo (United States), Carl Arbesman
soon reached a leading position in American allergology, both
in terms of teaching and in terms of clinical research. He
established a real school with numerous pupils, who have
affected a lasting inﬂuence on clinical American allergology.
Carl Arbesman was an exceptionally kind, open, and friendly
personality, very open to the world and actively interested in
international exchanges. He played therefore a very active
role in IAA, ﬁrst as secretary-general, then as president. His
premature death shortly before the 1982 congress in London
was a big blow to the organization (Fig. 11).
Jack Pepys (1914–1996)
Coming originally from South Africa, Jack Pepys
established himself after World War II as a leading ﬁgure
TABLE 5. IAACI/WAO Presidents (1951–2011)
2010–2011 Richard F. Lockey (United States)
2008–2009 G. Walter Canonica (Italy)
2006–2007 Michael A. Kaliner (United States)
2003–2005 Carlos E. Baena-Cagnani (Argentina)
2000–2003 Allen P. Kaplan (United States)
1997–2000 S. Gunnar O. Johansson (Sweden)
1994–1997 Albert K. Oehling (Spain)
1991–1994 Terumasa Miyamoto (Japan)
1988–1991 Jacques P. Charpin (France)
1985–1988 Alain L. de Weck (Switzerland)
1982–1985 Jack Pepys (United Kingdom)
1976–1979 Enrique Mathov (Argentina)
1979–1982 Carl E. Arbesman (United States)
1973–1976 Tiuzi Sindo (Japan)
1970–1973 Max Samter (United States)
1967–1970 Umberto Seraﬁni (Italy)
1964–1967 Bram Rose (Canada)
1961–1964 Carlos Jiménez Diaz (Spain)
1958–1961 Bernard M. Halpern (France)
1955–1958 Samuel M. Feinberg (United States)
1951–1955 Fred W. Wittich (United States)
FIGURE 8. Samuel M. Feinberg (United States), president
(1955–1958).
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of British allergology. As the head of the Allergy Division of
the Brompton Hospital, he engaged for more than 40 years in
active fundamental and clinical research in allergy. Many of
his contributions and discoveries have remained classical and
have durably inﬂuenced clinical practice and patient care.
Among these, the characterization, identiﬁcation, and etio-
logical clariﬁcation of the group of respiratory diseases
known as allergic alveolitis or “farmer’s lung” remain prob-
ably the most remarkable (Fig. 12).
Jack Pepys became universally recognized as one of
the most respected world leaders in our ﬁeld in the 1980s.
Accordingly, he also played a major role in the IAACI for
almost 2 decades. His engaging personality, together with his
perceptive wit, and the constant support of his lively wife Rhoda
contributed mightily in making that couple unforgettable ﬁgures.
Alain de Weck (1928)
As a pupil of Werner Jadassohn, a well-known Swiss
dermatologist and allergologist, and of Herman Eisen (United
States), Alain de Weck established in 1970 the Institute of
Clinical Immunology at the University of Bern, which became
for the next 25 years a well-known center of allergy and
immunology research in Europe. He became early associated in
1970 with the IAACI, in which sequentially as treasurer, vice
president, president-elect, president, past president, and histo-
rian, he remained associated for 30 years, almost a caricature of
longevity in ofﬁce! With his somewhat unique involvement
with international allergology (IAACI) and immunology
(IUIS), he contributed to the close links that existed between
allergy and immunology during the 1980s, including several
concrete projects such as allergen standardization. After an
agitated tenure as treasurer, he devoted also much of his energy
to put IAACI ﬁnances on a stable footing (Fig. 13).
Jacques Charpin (1921–1998)
After the generation of Pasteur Valéry-Radot and Bernard
Halpern, Jacques Charpin, originally a pneumologist, became in
the 1960s and remained for 30 years the uncontested leader of
French allergology. At the Department of Pneumology of the
Hospital Sainte Marguerite in Marseille (France), he developed
research and educational activities that attracted a large number
of pupils and practitioners. His allergy handbooks have
remained classical. Accordingly, he became also involved in
IAACI activities, ending up as president. Unfortunately, illness
prevented him to some extent from leaving his full mark in that
ofﬁce. With his highly distinguished appearance and personal-
ity, together with an open mind, Jacques Charpin was the
incarnation of the French “patron” at his best (Fig. 14).
Terumasa Miyamoto (1930)
As the head of the Allergy Division at the Department
of Medicine and Physical Therapy of the University of Tokyo
for more than 20 years and as teacher of a whole generation of
FIGURE 9. Carlos Jimenez Diaz (Spain), president (1961–
1964).
FIGURE 10. Max Samter (United States), president (1970–
1973).
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Japanese allergologists, Terumasa Miyamoto became a tow-
ering ﬁgure of Japanese allergology, as none before him. At
least so it appeared in international circles, where his open
personality and his ability to defend his always well-balanced
point of view made him a welcome partner. He has been
largely responsible for the opening of Japanese allergology
and allergists to the world since 1980 and also, through
exchange of research fellows, for the creation of numerous
personal ties. At the same time, the high quality of Japanese
allergy and immunology research broke the linguistic barriers
and became known worldwide. This development found its
recognition at the excellent IAACI congress in Kyoto, 1991,
which Terumasa Miyamoto organized (Fig. 15).
Alberto Oehling (1928)
Alberto Oehling, of German origin but Spanish educa-
tion, created in 1961 the ﬁrst specialized Department of
Allergology at the University of Navarra in Pamplona (Spain)
and remained the director of that institution for more than
30 years. In that position, he exerted considerable inﬂuence
on the development of clinical allergology but also, through
his numerous pupils, in the whole of Latin America. Beyond
clinical duties, the department also became a well-known
center of allergological research in Europe. No wonder that
Alberto Oehling became soon the leading representative of
the Spanish-speaking allergy world and involved in IAACI
affairs. This was crowned by his presidency of the 1997
ICACI in Cancun (Fig. 16).
S. Gunnar O. Johansson (1938)
The ﬁrst contact of Gunnar Johansson with allergy
occurred very early in his medical career where, together with
his teachers Wide and Bennich, he identiﬁed a myeloma with
properties similar to the long-sought natural “regains,” charac-
terized about the same time by the Ishizakas. This special class
of antibodies, responsible for the majority of allergic diseases
under the name of IgE, was a major discovery with multiple
clinical applications and consequences. As the head of the
allergy group of the Department of Medicine at the Karolinska
Institute in Stockholm (Sweden), Gunnar Johansson remained
a pillar of allergy and IgE research for 3 decades. Since 1990,
he became also actively engaged in IAACI affairs. He has been
largely responsible for the reforms and orientation that have led
the old IAACI toward the new WAO since 2000 (Fig. 17).
The General Secretaries and Their Terms
in Office
Charles H. A. Walton (1958–1966)
Charles Walton was a fellow of the American and
Canadian allergy societies. He served on the Medical Council
of Canada, including president, from 1970 to 1971.
A. William Frankland (1967–1970)
A. William Frankland has been a leading clinical
allergologist in the United Kingdom for more than 50 years
and to a large extent responsible for the recognition of allergy
in that country. I last met him at the World Allergy Congress
in Munich in 2005. He is still going strong at the mature
age of 95.
FIGURE 11. Carl E. Arbesman (United States), president
(1976–1979).
FIGURE 12. Jack Pepys (United Kingdom), president (1982–
1985).
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Carl E. Arbesman (1970–1973)
See his biography in the section on presidents.
L. L. Henderson (1973–1985)
L. L. Henderson was for many years the head of the
Allergy Division of the Mayo Clinic in Rochester (United
States), one of the major training centers in allergology. He
served the IAACI for an unprecedented 5 terms, 1 as treasurer
and 4 as secretary-general. His competence and dedication
made him totally identiﬁed with the association.
Oscar L. Frick (1985–1991)
Oscar Frick is a pediatrician allergologist and was the
head of pediatric allergology at the University of California at
Los Angeles (United States). Beyond a successful career
within the AAAAI, he soon developed an interest for
international affairs and for IAACI, where he became
a prominent American delegate.
Allen Kaplan (1991–1997)
Allen Kaplan, after an initial training in Boston under
Frank Austen, became a well-known research scientist in the
ﬁeld of allergy mediators. He also soon developed international
contacts and ties, which brought him to various leading positions
within the IAACI, culminating with the presidency in 2000.
Carlos E. Baena-Cagnani (1997–2000)
Carlos Baena-Cagnani, as an allergologist residing in
Cordoba, Argentina, soon acquired a reputation in Argenti-
nean and Latin American allergy associations. He became one
FIGURE 13. Alain L. de Weck (Switzerland), president
(1985–1988).
FIGURE 14. Jacques P. Charpin (France), president (1988–1991).
FIGURE 15. Terumasa Miyamoto (Japan), president
(1991–1994).
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of the most prominent Latin American delegates within the
IAACI, which culminated in the presidency in 2003.
The Treasurers
E. Bruun (1958–1967)
E. Bruun was at the time the most prominent clinical
allergist in Denmark and an uncontested leader of the ﬁeld in
his country. He was also the founder of one of the ﬁrst allergy
journals, Folia Allergologica, later the main European Jour-
nal of Allergy.
L. L. Henderson (1967–1970)
See biography as secretary-general.
J. A. Jamar (1970–1973)
J. A. Jamar was at this time a prominent Belgian
allergologist, well appreciated in European and international
circles. He disappeared much too prematurely from the scene
and IAACI.
Alain L. de Weck (1973–1979)
See biography in section on presidents.
Israel Glazer (1979–1985)
Israel Glazer is a clinical allergologist practicing in Tel
Aviv, with an extended network of international colleagues and
friends. He was associated for several years with the IAACI
and successfully organized the congress in Jerusalem in 1979.
Robert J. Davies (1985–1994)
As a younger colleague of Jack Pepys and an estab-
lished researcher and teacher in allergology, Robert Davies
played an important role in the organization of the London
Congress in 1982. In recognition of his organizational skills,
he was appointed IAACI treasurer in 1985, a position that he
kept for an unprecedented 3 terms.
Michael A. Kaliner (1994–2000)
Michael Kaliner was the head of the Allergy Laboratory
of the National Institutes of Health in Bethesda (United
States) and then was the head of the Asthma Clinic at the
Washington Hospital and has played a prominent role for
decades in fundamental and clinical allergy research. He also
became closely tied with the IAACI in various ofﬁces,
culminating with the presidency in 2005. He was also one
of the main architects of the 2000 IAACI reform and its
transformation into the WAO. He is the current historian on
the WAO Board of Directors.
IAACI COMMITTEES
For its ﬁrst 40 years of existence, IAACI committees, as
established and prescribed by the constitution, were the only
instruments responsible for IAACI activities and vehicles of
its inﬂuence on the allergological world. It must be acknowl-
edged that for the ﬁrst 30 years, until the 1980s, IAACI
committees were mostly paper tigers with very few teeth and
concrete results. This was due to the fact that these
committees could only meet in person every third year at
the time of IAACI congresses and that business had to be
achieved by correspondence. Furthermore, the position of
IAACI committee member was largely honorary, nomination
being proposed by the president and approved by the
Executive Committee, often more based on regional repre-
sentation than personal commitment to the task. Nevertheless,
FIGURE 16. Alberto K. Oehling (Spain), president (1994–1997). FIGURE 17. S. Gunnar O. Johansson (Sweden), president
(1997–2000).
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it was often by work in the committees that several young
leaders emerged and left their mark, ultimately as members or
ofﬁcers in the Executive Committee.
Matters began to change in the 1980s, where some
committees started very concrete projects such as in standardi-
zation and education, often in cooperation with other interna-
tional organizations (eg, IUIS, WHO). In the 1990s, beyond and
aside of the “legal” IAACI committees, several special programs
developed (eg, World Allergy Forum, Perspectives of Allergy,
GLORIA), often with their own advisory boards.
Nominating Committee
According to the original IAACI constitution and
practically for 50 years, the role of the Nominating Committee
merely was to nominate every third year the ofﬁcers and
members of the Executive Committee to be elected by the
House of Delegates. The committee was chaired by the
departing president, who had thereby a decisive inﬂuence on
his own succession. It was composed of 12 members who
represented 4 regions (Europe, North America, Latin America,
and Asia) and were nominated by the president. For
the appearance of better democracy and representation, the
12 members of the Nominating Committee were in general not
members of the Executive Committee but were then also little
familiar with IAACI affairs.
The Nominating Committee had an important impact on
the future of the association. As indicated by an abundant
correspondence, the nominating procedure often gave matter to
intense discussions behind the scenes, and this correspondence
is quite revealing about personalities and trends of the time. It
sometimes, but seldom, reﬂected real clashes. At the end, the
Executive Committee, based on the proposal of the Nominat-
ing Committee, always proposed a full slate, which was usually
approved globally without discussion by the House of
Delegates.
There is no doubt that this procedure favored some
degree of inbreeding and gave a long and lasting inﬂuence to
those presidents who had the diplomatic skill and the interest
to use that power. But it also provided for the continuity in
policy, which the establishment of new disciplines at the time
absolutely required.
Credentials Committee
The Credentials Committee is in charge of checking
whether societies applying for membership to WAO are
established in good standing and fulﬁll the conditions for
membership set forth by the association. These conditions
have somewhat changed with time, becoming more rigid, in
particular about the minimal number of 30 members and the
demonstration of regular activities and periodical elections. In
this way, the WAO has attempted to avoid loading the
association with ephemeral groups reﬂecting merely the
ambition of their president and sole founder, as happened
sometimes in the past. The state of activity and size of the
member societies over time are well reﬂected in Table 2.
For some time before 1990, much debate was held
about individual membership in the IAACI for allergologists
active in a country where no allergy society existed. This
category of members has always remained very small, below
20, and it was abolished in 1991.
Standardization Committee
Allergens, the required diagnostic and therapeutic
working tools of the allergist, being extracts from various
and complex biological sources, have been since the begin-
ning very heterogeneous biological mixtures. This has
resulted not only in qualitative but also in quantitative
insecurity because the biological potency of allergens could
not be determined in a meaningful manner. This state of
affairs resulted not only in dangers and difﬁculties for the
patients but also in wide differences in manufacturing quality
and market regulation.
Despite numerous paper studies and expressed wishes
about allergen standardization, very little was done concretely
about it until 1977. At that time, under the impulse of some
regulators (H. Baer and B. Brighton), manufacturers (B. Guérin),
consumers (P. Norman and A. de Weck), and scientists
(H. Loewenstein), a new effort was started in the form of a joint
Allergen Standardization Committee between the IAACI and the
IUIS. This committee developed an original approach to the
problem in several ways. First, it encompassed all professionals
directly concerned by allergens: the manufacturers, the consum-
ers (allergists), the scientists studying allergen structures, and the
regulators setting up criteria for access to the market. Second, the
purpose of the committee was not only to talk or write about it
but also to do something very concrete to harmonize and
standardize allergen manufacture, analysis, and regulation
worldwide.
In a ﬁrst step, the committee endeavored to standardize
the methods used to analyze allergens qualitatively and
quantitatively, which had been made possible by new technol-
ogies (radioallergosorbent inhibition, immunoblotting, etc.).
Second, it established the goal to produce allergen preparations
suitable as International Standards of reference, useful for
quality control of allergen manufacture and also for regulation
purposes. Such standards would be evaluated and validated by
multicentric studies. Hence, a considerable scientiﬁc and
ﬁnancial effort was performed in the 1980s, culminating in
the establishment of some International Standards or Reference
Preparations.
The allergen market represented at that time about US
$300 to US $400 million worldwide, and the main incentive
for manufacturers and regulators to support actively the IUIS/
IAACI standardization program was the hope to achieve
worldwide unity in qualitative and quantitative evaluation
and regulation of allergens. Unfortunately, it became clear
after about 10 years that this goal had not been achieved.
Retrospectively, several reasons were responsible for this rel-
ative failure. The ﬁrst one is that due to the complexity of the
problems, some of the preparations proposed as International
Standards were found to have some ﬂaws and were not uni-
versally accepted as references, particularly by some perfec-
tionists. The second is that some regulators, under the
pressure of national considerations, could not wait for the
coordinated international process to be completed but started
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to edict new regulations and standard procedures of their own.
This was particularly the case for the USFDA, which became
very active around the end of the 1980s and developed
a whole set of procedures and standards independently. This
American move ultimately prevented harmonization between
Europe and the United States. Thus, the main incentive for
manufacturers to support the program disappeared, and
the ensuing uncertainty even enticed some manufacturers to
develop criteria and unitages of their own as marketing argu-
ments, adding thereby to the confusion. Nevertheless, there
can be no doubt that the activities of the IUIS/IAACI
Standardization Committee between 1980 and 1995 have
contributed decisively to improvement in quality control,
manufacture, and market regulation of allergen. While the
potency of marketed allergens could in the 1980s vary by
a factor of 1000 under the same tag, this variability has been
reduced to a factor of 2 to 5, considerably reducing the risks
for the patients and improving the efﬁcacy of speciﬁc immu-
notherapy. Besides the development of allergen standards and
procedures, the IAACI/IUIS Allergen Standardization Com-
mittee has also mightily contributed to the ﬁeld in educational
terms, sponsoring in 1979 the Paul Ehrlich Seminar, the ﬁrst
and only specialized meeting devoted to standardization and
regulation of allergens.
Since the early 1990s, new technological approaches
such as monoclonal antibodies and recombinant allergens
have opened new possibilities for standardization. The IAACI
supported this development by organizing a course in Vienna,
1995, to disseminate these technologies among scientists and
manufacturers. Around 2000, a European Union–supported
project (CREATE) was also started with the goal to develop
such new technologies as standardization tools. This project
has revealed even more complexities in terms of physico-
chemical identities and immunological properties of aller-
gens, genetic responses of the patients, and viability of the
procedures used. For perfectionists, the amount of work to be
done on each extract seems to exceed the ﬁnancial limits set
by a limited market. It seems therefore clear to a pragmatic
eye that compromise and a sense of reality will have to inspire
consumers and regulatory authorities.
It seems nevertheless regrettable that since 2000 both
the IAACI and the WHO have apparently, in the eyes of this
involved historian, deﬁnitely dropped standardization from
their priorities. Standardization, which was still a strategic
goal in the early strategic plans of 1998, was formally
dropped in 2000. And the IAACI/IUIS joint effort seems
to have ceased as well, possibly because few or no IAACI
executive members have ever been personally actively
engaged in that ﬁeld, as was the case before. The recent
reports of WAO on allergen standardization do not testify to
active and concrete involvement of WAO in that ﬁeld any
more. It must be recognized that the increasingly complex
matter probably discourages all but a few specialists and also
that concrete work on allergen standardization is difﬁcult to
ﬁnance because the ﬁnancial interest of the industry in that
ﬁeld is rather marginal.
Nevertheless, the high quality of allergens is a pre-
requisite for a high-quality allergy practice, and it remains in
my view regrettable that IAACI, which had made mighty
contributions in the 1980s, has apparently not maintained that
strategic priority. The same can be said for the WHO, which
had strongly supported the IUIS/WHO effort in the past but
has obviously switched priorities. Since 2000, allergen
standardization and standardization in allergy no longer ﬁgure
on the agenda of the WHO Expert Committee on Biological
Standardization or of the Department of Vaccines and Bio-
logicals, as was the case before. These are the international
groups responsible for biological international standardization
in medicine at the world level.
Training and Specialization in
Allergy Committee
At the time of the foundation of the IAA in 1951, most
national allergy societies were of very recent origin and
practically none of their members had been trained as
allergists but as pneumologists, dermatologists, otorhinolar-
yngologists, microbiologists, and so on. Allergy was also not
part of the curriculum for medical students.
It is therefore no wonder that training in allergy and
recognition of allergy as a medical specialty or subspe-
cialty became a major interest for the IAA. This was the
start of a long struggle with varying degrees of success
because resistance to change and move from tradition can
be quite strong in academic circles. Progress was therefore
erratic and varied from country to country. Nevertheless,
over the past 30 years, allergy as a topic for medical
teaching and as a practical medical specialty has been
increasingly recognized throughout the world. After 60
years, the struggle for recognition of allergology as
a medical specialty or subspecialty is not yet over in
various countries of the world.
A major factor for higher awareness has been the
increasing recognition of allergic diseases as a serious public
health problem by various national and supranational author-
ities, in particular documents and guidelines provided by the
WHO in cooperation with the IAACI and IUIS. On that basis,
national allergy societies have seen their initiatives and
requests to their own national public health and academic
authorities well supported.
Since the 1990s, the IAACI/WAO has taken the
responsibility of extending the information and teaching of
allergy not only to allergists but also to other medical
specialties, to paramedical personal (eg, nurses), to the
allergic patients, and to the general public. Manifestations
such as the World Allergy Day (now the World Allergy
Week) or the World Asthma Day are examples of these new
kinds of activities. Education in allergy at various levels has
become a major strategic goal. Another activity of this type,
in which the IAACI/WHO participated, is the WHO Global
Alliance against Respiratory Diseases (GARD) program. All
these represent a considerable personal and ﬁnancial effort. Its
impact may only be middle or long term and is difﬁcult to
measure and evaluate. For other special educational IAACI
programs, such as the Perspectives of Allergy or World
Allergy Forum, started by the IAACI in the 1990s (see below)
and funded through unrestricted educational grants from
pharmaceutical companies, the operations were in general
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directed by ad hoc advisory boards rather than by the IAACI
Committee on Specializiation and Training.
Editorial Committee
For almost 40 years, the role of the Editorial
Committee was reduced to supervising the publication of
the Proceedings of the International Congress on Allergy
and Clinical Immunology triennial congresses. Since for
a number of years, the publishers of such proceedings
changed, often following the whim of the local congress
president, little continuity in editorial procedures and pre-
sentation could be achieved. This improved somewhat
between 1988 and 2000, in which the same publisher
(Hogrefe & Huber) could establish a series with the same
publication standard.
Another task of the Editorial Committee was to
supervise the production, at some periods, of an IAACI
newsletter. These were quite irregular, never more than
once a year. The longest effort in that respect was that
originated and maintained by Max Samter under the heading
Horizons, appearing irregularly between 1980 and 1988.
Since the arrival of Internet and a Web site for the IAACI/
WAO, regular news contributions have considerably im-
proved communication to and among members.
In 1988, the IAACI took the initiative, supported by the
publisher Hogrefe & Huber, to create a bimonthly journal
under the name ﬁrst of Allergy and Clinical Immunology News,
then Allergy and Clinical Immunology International. This
adventure was successfully pursued for 20 years (see below)
until it was replaced by the World Allergy Organization Jour-
nal (WAO Journal), which is an online-only journal.
Awards Committee
Like most societies and associations, the WAO has
endeavored to offer special recognition to some of its most
distinguished members and to some individuals who had
played an important role in the development of the ﬁeld. In
the early days, this was done in the form of honorary
membership. The list of IAA honorary members in 1970
included the following 16 personalities: A. F. Coca (1951),
Sir Henry Dale (1951), R. Doerr (1951), C. Frugoni (1951),
D. M. Heidelberger (1951), P. Karrer (1951), R. Otto
(1951), P. Portier (1951), R. Rössle (1951), B. Schick
(1951), F. Wittich (1961), F. M. Rackeman (1961),
C. Jimenez Diaz (1964), S. M. Feinberg (1961), H. Osgood
(1961), and P. Valéry-Radot (1964).
Since 1970, no honorary memberships have been
granted but 3 types of awards have been created. Achieve-
ment Award: This award is bestowed on individuals having
distinguished themselves by important scientiﬁc contribu-
tions to the ﬁeld of allergy and clinical immunology. Henry
Hyde Salter Award, named after a well-known British asth-
mologist from the 19th century, destined to clinical allergol-
ogists having distinguished themselves as clinicians and
clinical teachers. Distinguished Service Award for people
having performed particular service to the association. The

























































































































































































































































































































































































































































































































































































































WAO Journal  November 2011 First 50 Years of IAA/IAACI/WAO
 2011 World Allergy Organization 225
Environmental/Aerobiological Committee
When it was realized how much the indoor and outdoor
environment may inﬂuence the epidemiology of allergic
diseases, it was decided to create a committee to provide
comparative studies at the international level. One of the major
and most fruitful initiatives has been to organize special
workshops on house dust mite allergy. This was at the time
a very important topic clinically since responsible for many
respiratory allergies but at the same time some kind of orphan
problem. Involved are not only clinicians but also entomolo-
gists, mite specialists, insecticide producers, household techni-
cians, and the like. These groups had normally very little
opportunity to meet. A series of “mite workshops” ensued, the
ﬁrst in Oxford in 1985, the second in Bad Kreuznach in 1987,
and the third in Cuenca in 1995. These workshops have might-
ily contributed to our knowledge about dust mite allergies and
about the development of new means to control them.
CONSTITUTION AND BYLAWS COMMITTEE
The ﬁrst IAACI constitution of 1951 was largely
inspired from the Anglo-Saxon jurisprudence. It was rather
formal and rigid, providing numerous ﬁxed rules in the
nomination and electoral procedures.
There were then many years where the Constitution and
Bylaws Committees had nothing to do. However, some
pragmatic changes were introduced stepwise, mostly to
enable the Executive Committee to take some unforeseen
initiatives, such as creating new committees, setting up
special projects and meetings, redeﬁning criteria for member-
ship, and modifying slightly the electoral rules. The 1991
constitution was therefore still very similar to the original one.
Matters changed drastically in 1998, when under the
impulse of Gunnar Johansson, the IAACI president, and Richard
Lockey, chair of the IAACI Constitution and Bylaws Commis-
sion, a broad discussion was engaged about a strategic plan for
the IAACI and a new constitution. For the ﬁrst time, a detailed
discussion and a record of various individual opinions were
kept, providing interesting insights into the strategic perspectives
of IAACI. This ended up in a proposed new constitution, which
was then adopted at the Sydney Congress 2000.
The major changes in that constitution included the
following:
• the term of IAACI Congresses and Executive Committee
(renamed the Board of Directors) elections to a 2-year
rotation instead of 3;
• the change of name IAACI to WAO;
• new deﬁnition of mission as “a global alliance of allergy
societies to advance excellence in clinical care, research,
education, and training”;
• incorporation according to Wisconsin (United States)
law instead of Swiss law;
• 3 categories of members: full members, afﬁliate (voting),
and associate (nonvoting);
• better deﬁnition of membership rules (application and
maintenance in good standing);
• meetings of the Board of Directors at least once a year.
From this historian’s point of view on the ﬁrst 50 years
of IAA/IAACI/WAO, there is no doubt that the change from
the 20th into the 21st century brought with it some drastic
changes in the structure, the mission, and the perspectives
of the old association. The changes were well prepared and
extensively discussed, although the formal consultation pro-
cess did not include most of the older ofﬁcers and Executive
Committee members who had been in charge in previous
years. Some would probably have manifested additional
remarks and amendments. But reforms are seldom achieved
by old people. It will be the task of the 21st century WAO
historians to evaluate whether the new directions have
brought full satisfaction or whether some of the old strategies
might deserve renewed consideration.
SPECIAL PROJECTS AND THE WHO
Until 1976, the IAACI had practically no other
activities than its triennial congresses. In 1977, under the
sponsorship of the WHO and in association with the
immunologists of the IUIS, it started an ambitious allergen
standardization program, with the goal to establish WHO-
recognized International Reference Preparations and to unify
worldwide regulation and unitage of allergens. Also together
with the same partners, the IAACI developed new concrete
approaches for deﬁning teaching in allergy and clinical
immunology.
This led naturally to a broader involvement in medical
and allergy education, not only for the allergists themselves
but also for other specialties, for allied health professionals,
and for the general public. This led to the development of
special educational programs, some solely sponsored by the
IAACI and others in cooperation with the WHO.
As programs solely sponsored by IAACI must be
particularly mentioned Global Aspects of Allergy and Asthma,
Perspectives of Allergy, and World Allergy Forum. These
programs were made possible by sizable ﬁnancial contribu-
tions from some pharmaceutical companies, which saw in
them potent indirect marketing tools. The Perspectives of
Allergy program enabled the WAO to organize special allergy
workshops, courses, and sessions between its own con-
gresses, either on their own or as part of a congress of another
international group (eg, European Respiratory Society). It
also produced a strategic paper on education in allergy, the
so-called Meadowood Manifesto.
The World Allergy Forum program had similar educa-
tional purposes but was restricted to the allergy community
and endeavored to support WAO regional member societies
by ﬁnancing symposia at regional allergy meetings. This
program started in 1996.
Among the programs jointly sponsored by WHO and
IAACI, organized since the 1990s, ﬁgure GARD, GLORIAd
the Global Rhinitis Initiative (a WAO program which WHO
was invited to participate in but declined), and ARIA. These
programs were developed to produce educational materials and
internationally recognized guidelines for the management of
rhinitis and asthma. However, GLORIA expanded to become
the Global Resources in Allergy program of the WAO and now
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encompasses all themes in allergy. The discussion of IAACI/
WAO special projects brings into focus the historical perspec-
tives of relationships with the WHO.
As an ofﬁcial expert in immunology of the WHO
(1973–2003) and directly involved in the recognition of the
IUIS as a nongovernmental organization (NGO) in ofﬁcial
relationships with the WHO, I have been associated from
the inside with most activities of WHO concerning allergy
and immunology (allergen standardization and regulation,
vaccine development, parasitic diseases, acquired immunode-
ﬁciency syndrome, antifertility vaccines, etc.) for almost 30
years. In the past decade, I have continued to follow these
from the various WHO reports and notices on the Web. In
view of the essential role of the WHO in public health world-
wide, I believe therefore that a historical note about the rela-
tionships between the WHO, the IAACI, and allergy in
general is of medical historical interest.
The interest of the WHO for immunology, particularly
in the ﬁelds of vaccination against epidemic (eg, smallpox
eradication, poliomyelitis) and parasitic diseases, arose quite
early in the 1950s and 1960s. This interest was documented
by the establishment of an Immunology Unit at the WHO
Geneva headquarters, ﬁrst under the direction of Howard
Goodman, then Giogio Torrigiani, and Paul-Henri Lambert. It
was also manifested by the creation of the whole network of
immunology institutes, particularly in Africa, devoted pri-
marily to diagnosis, prevention, and therapy of parasitic
diseases. At that time, intense cooperation had developed
between the IUIS, IAACI, and WHO, helped by the fact that
many scientists in executive positions in these associations
were also personally and directly involved in those WHO
projects. The majority of these projects had very concrete
goals for improving public health, including the development
of products and reagents (vaccines, allergen standards,
immunological standards, evaluation of new diagnostic
technologies, guidelines for manufacture and quality control,
antifertility vaccines, etc.).
It is obvious from the study of the WHO andWAO reports
since about 2000 that priorities and organization have somewhat
switched from the previous decades. Projects with impact on
allergy and immunology have been rebaptized in terms of
“Global Alliances or Global Programs,” and responsibility for
these programs has been attributed to various WHO departments
(eg, Vaccines and Biologicals, Noncommunicable Diseases). At
the same time, the number of allergy associations and societies
participating inWHO programs has dramatically increased, a wel-
come process in terms of worldwide representation but possibly
a nefarious one in terms of efﬁciency.
At present, the most imposing WHO program related
to allergy seems to be GARD, which includes almost
200 national and international organizations (WAO is only
one of them). But a striking point in most of these efforts is that
the main emphasis has been put on the production of paper
(or electronic) guidelines and educational materials rather than
on direct development of new products and technologies.
At the end of the 1990s, the IAACI had set as a major
priority the strengthening of its ties with the WHO and in
particular to be recognized by the WHO as an NGO in ofﬁcial
relationships, like the IUIS and a number of similar medical
organizations. Such a status has numerous advantages, such
as active participation in WHO affairs and strategic planning.
In 2000, the manifested intention of the IAACI was clearly to
become the privileged partner of the WHO in terms of
worldwide allergy. This was also a major motivation for the
transformation of the IAACI into the WAO. The Prevention
of Allergy and Allergic Asthma program started in 2002 as
a joint WAO/WHO venture. Funded by the WAO, this project
resulted in a joint meeting report but led eventually, as a result
of changes in WHO policy, to the publication of a book by
the WAO in 2004, without the involvement of the WHO. A
decade later, one must recognize that this effort at collabo-
ration has largely failed. In 2010, the IAACI still does not
ﬁgure on the list of WHO-recognized NGOs. Worse, the main
relevant WHO program in allergy, GARD includes WAO
only in a crowd of national societies and other groups. Most
of the prominent leaders in GARD represent other allergy
groups and have no executive function in WAO. This
regression, in respect to the close relationship between the
WHO and IAACI, which existed from 1975 to 1995, is due to
several factors.
One factor in the failure of the relationship is that most
IAACI ofﬁcers or directors were no longer personally
involved in WHO affairs. The other is the evolution within
the WHO itself. While for more than 30 years allergy and
immunology were coordinated by a single WHO Immunol-
ogy Unit, the ﬁeld is now divided under several headings and
departments. Accordingly, the paradox seems to be that
allergy as a discipline no longer has at WHO the same
priority, as was the case 30 years ago, despite its increasing
signiﬁcance in public health. This is compounded also by the
fact that a number of very concrete public allergy programs
and projects, such as GA2LEN, CREATE, or PREVALL, are
supported by the European Union, outside the WHO and
WAO organizations.
To my view as a historian, now obviously as an
outsider, this evolution is regrettable, more for WAO than
for WHO, which will always ﬁnd the experts it needs. But
there is little doubt that the IAACI, now the WAO, has in the
past 10 years lost the preeminent place in allergy, which it
played at the WHO in earlier years. This may be compensated
in part by a larger role in terms of production of guidelines,
educational materials, graduate courses, and establishment of
numerous new national allergy societies, particularly in
emerging countries. But the WHO remains the main channel
by which medical affairs may be effectively and durably
inﬂuenced, and the current state of apparent mutual benign
neglect should be, in my view, addressed effectively.
ORGANIZATION AND FINANCES
Executive Secretariat
Until 1967, the IAACI was not a professional organi-
zation relying on the services of a permanent professional
secretariat. All administrative duties (correspondence with
member societies, congress organization, levy of member
contributions, etc.) were performed by the personal secretariat
of the current president and/or secretary-general.
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After the 1967 Montreal Congress, which had been
largely organized by a local Canadian professional company
directed by Sue Edwards, that company (Executive Directory
Ltd) was retained by the IAACI to create and manage
a permanent secretariat, and the position of executive secretary
was created. This was a small operation but sufﬁced at the time
to administer IAACI affairs, which amounted to a little more
than organizing a congress every third year. However, at the
occasion of the 1976 Buenos Aires Congress, due to illness and
absence of Suzanne Edwards, the system broke down and I
was left alone as treasurer to pick up the pieces.
The Executive Directory company was transmitted to
Mr R. O’Neal (Executive Suite Ltd), who was appointed by
the IAACI as replacement at the Jerusalem Congress of 1979.
Unfortunately, this new executive secretariat proved totally
dysfunctional and even committed various improprieties,
which obliged some members of the Executive Committee
to unusual legal steps to protect still meager IAACI assets.
After evaluating various proposals, the Executive Com-
mittee decided to trust its administrative affairs into the hands of
the EDI, chaired by Mr R. O’Neil in Milwaukee (United
States). The company had been managing the business of the
AAAAI for a number of years. This was obviously an excellent
choice because the EDI still is the seat of WAO secretariat after
28 years of operation. In particular, the EDI took an increasing
role in managing and ﬁnding ﬁnances for numerous special
projects, as mentioned above. In the organization of WAO
congresses, the EDI took a useful supervisory and advisory role,
ensuring a welcome continuity. In some congresses, particularly
on the American continent, it took the main administrative
responsibility for the congress organization (Washington,
1985, and Cancun, 1997). The EDI has therefore taken since
1982 an important part in the extension and development of the
IAACI/WAO and ensured administrative and conceptual stabil-
ity during varying presidencies. The incarnation of that role was
for more than 15 years Rick Iber from EDI, a man with remark-
able professional and diplomatic skills.
At this time where WAO, as successor of the IAACI, is
increasingly engaged in various activities requiring adminis-
trative and conceptual support, the role of the executive
secretariat remains essential. The more as the shorter 2-year
tenure in ofﬁce is bound to make WAO ofﬁcers less
knowledgeable about WAO affairs and less efﬁcient in
long-term endeavors.
Finances
In its ﬁrst 30 years of existence, IAACI ﬁnances were
run on a shoestring and were a constant source of worry for
those in charge. The only source of revenue was membership
dues, ﬁxed in 1951 at 2.50 Swiss francs per member and
never raised in 40 years! The constant reevaluation of the
Swiss franc in respect to other currencies attenuated some-
what the stagnation in dues. But during all the years between
1950 and 1976, the IAACI assets oscillated between US
$40,000 and US $50,000 and so the Argentine debacle of
1976 with its US $36,000 deﬁcit almost wiped us out. In
1994, the dues were raised for the ﬁrst time to 5 Swiss francs
per member, a move that created some bad blood, soon
resorbed, among some of the member societies. But it also
considerably ameliorated the ﬁxed ﬁnancial basis of the
association. From there on, the basic annual budget oscillated
between US $100,000 and US $150,000 (Table 7).
Around 1980, the budget of the triennial IAACI
congresses had increased from US $200,000 at the onset
1970 to the US $600,000 range. The IAACI was by consti-
tution pocketing eventual congress proﬁts but was also fully
responsible for losses. My time as IAACI treasurer made me
acutely aware of the risks incurred by an association manag-
ing million dollar events while holding only US $40,000
assets. Since then, one of the major ﬁnancial goals has been
to ensure steady proﬁts from the IAACI congresses, by var-
ious means (levy of a 12% IAACI due on registration fees,
optimization in the quest for sponsors and exhibitors, strict
control of expenses, etc.). Indeed, between 1988 and 2000,
the IAACI congresses saw their budgets increase to about
US $3 million and their proﬁts rise accordingly. In addition,
special contributions by the pharmaceutical industry, particu-
larly for deﬁned educational programs (eg, Perspectives of
Allergy), funded important special projects and contributed
to increase the IAACI budget and proﬁts. By 2000, the
TABLE 7. Summary of Finances (1967–1999)
Evolution, Date
Finances IAACI (1967–1999),
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IAACI was ﬁnancially in a comfortable and secure position,
able to undertake the various activities encompassed by the
new WAO vision.
Finance and Audit Committees
The Finance and the Audit Committees were small
groups, usually composed of the president and the treasurer
and a few individuals believed to be ﬁnancial wizards. Their
role was to advise the Executive Committee about the budget,
the management of IAACI assets, and the soundness of its
accounting.
Having been involved in such IAACI activities for
many years, I must recognize that these committees, like
for many medical associations, play a perfunctory role and
do not have the means to give professional advice and
control. The life of these committees was therefore rather
quiet, with the exception of the enforced change of




For many years, the only publication of IAACI was the
Proceedings of the IAACI Congresses, usually appearing as
a book, many times some months or even a year after the
congress. Such volumes were supposed to reﬂect the state of
the art and of science at the time. Some indeed may be
considered as such and still constitute very valuable sources
of information for present and future historians of allergology
and immunology.
But a weakness is that, in early times, publishers were
chosen by the congress presidents, often related to conve-
nience and local relationships. No guidelines were provided
to the editors for content or presentation. Therefore, no unity
of following editions ensued.
Between 1988 and 2000, this continuity was achieved
in cooperation with the publisher Hogrefe & Huber, institut-
ing a series called “Progress in Allergy” with identical criteria
and presentation. All references known for IAACI congress
proceedings are given in the individual reports above. At
various times, other reports on various topics, in particular
with WHO, have also appeared.
Newsletters
Communication between the IAACI and its members
was not a high priority in early days. It was in fact limited to
occasional correspondence between ofﬁcers and the ofﬁcials
of member societies in the form of typed circulars.
In the 1970s, however, mainly under the initiative and
editorship of the IAACI President Max Samter, a newsletter
entitled Horizons was started but appeared at very irregular
intervals, no more than once yearly. It contained essentially
news and meeting reports and announcements from IAACI
member societies plus an editorial. That newsletter was dis-
continued with the creation of Allergy and Clinical Immunol-
ogy News in 1988.
IAACI Journal
Already in the early 1980s, the IAACI Executive
Committee had realized that one of the most efﬁcient ways
to promote the cause of allergy worldwide would be to have
its own journal. Indeed, some of the major IAACI member
societies had been publishing highly successful journals for
many years, which were and still are the main tools of
scientiﬁc communication in the ﬁeld of allergy.
Therefore, around 1985, a ﬁrst negotiation was under-
taken with a popular magazine Allergy Today sponsored by
a pharmaceutical company and published by Elsevier. For var-
ious reasons, this negotiation did not succeed. Then, also in
view of the congress in Montreux in 1988, I was able to
develop with the publisher Hogrefe & Huber a concept that
culminated in the publication of the ﬁrst issue of Allergy and
Clinical Immunology News at the congress in October 1988.
That journal (6 issues per year) became highly popular, with
about 20,000 issues distributed every 2 months worldwide at its
peak. It remained the ofﬁcial journal of IAACI for 20 years and
generated both Russian and Japanese editions. Each issue con-
tained timely editorial, scientiﬁc and clinical reviews by prom-
inent invited authors, case reports, and general allergy news.
During its 20 years of publication, ACI News, later the Allergy
and Clinical Immunology International, had 3 editors in chief
who played a decisive role in the management and quality
standard of the journal: Alain de Weck (1988–1997), Allen
Kaplan (1998–2003), and Johannes Ring (2004–2007). The
major contribution of Dr Christine Hogrefe, from the publishing
house, has also to be emphasized. Not only did she bring pro-
fessional competence and scientiﬁc understanding, but she was
also instrumental in accepting the ﬁnancial burdens and risks
carried by the publisher during many early difﬁcult years.
Indeed, it turned out that achieving ﬁnancial security is more
difﬁcult for an international journal than for a national journal.
This is due on the one hand to difﬁculties in harvesting indi-
vidual subscriptions and on the other hand to the regional lim-
itations in marketing and advertising.
In 2007, the WAO Executive Committee decided to
discontinue publication of a paper journal, to be replaced
solely by the World Allergy Organization Journal (WAO
Journal), which is a fully online journal. As a matter of fact,
the replacement of scientiﬁc paper journals by electronic ones
has been discussed since the end of the 1970s and is a matter
of continuous debate. Several arguments may entice us to
replace paper by a screen, but the Internet has still not made
newspapers and books obsolete. The future will tell whether
the wider Internet-mediated distribution will have a more last-
ing effect than traditional papers.
CONCLUSIONS
The project to write a history of the IAA/IAACI/WAO
has been with me for a long time but there were always more
pressing tasks. Finally, the encouragement of the current
WAO historian, Michael Kaliner, and the conscience that
I am soon to be the only one left to report on more than
30 years of the association’s life have enticed me to plunge
into the papers and reports stored in my cellar. The project has
taken a life and a dimension of its own. The ﬁnal dimension is
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probably more than the usual reader will bear. On the other
hand, the sense of the whole endeavor is to leave as many as
possible of the signiﬁcant issues available for posterity.
I have taken the liberty to express sometimes personal
opinions and interpretations because this is also the task of the
historian. The second half of the 20th century has been an
exciting and fascinating time for allergy and immunology,
2 ﬁelds of medicine that have literally exploded during that
period. The history of the IAA/IAACI is also the history of
a relatively small group of scientists and physicians who have
shaped their discipline during their period.
One may rightfully argue that this group was too small,
too self-centered, undemocratic, and maybe stiﬂing for
younger forces. However, I believe that this group did a great
deal to promote scientiﬁc exchange and develop technologies
that were an improvement in medical practice and still beneﬁt
allergic patients today.
Obviously, the need for a broader approach, geared not
only to allergists, has been made obvious by the increasing
importance of allergic diseases as a public health problem.
The growth of trained allergists in various countries of the
world has also necessitated a broader framework of pro-
fessional organizations, with a larger and more open partic-
ipation of its members. This, however, together with shorter
times in ofﬁce, should not come at the expense of the long-
term commitments that are essential for efﬁciency.
I have been personally particularly impressed by the
direct and indirect effects that several concrete IAACI projects
(standardization, new technology courses, mite workshops,
guidelines for manufacturers, and quality controls) had in the
1980s to improve daily allergic practice. Since then, the WHO
and WAO seem to have given priority to educational materials
and particularly paper guidelines. Without denying their value,
I still wish to transmit to younger generations some innate
skepticism about the effectiveness of paper guidelines in really
changing and improving our modes of operation. Such guide-
lines are usually proclaimed around a table by so-called experts
of various opinions and represent a consensus about minor
denominators. When a controlled follow-up is made about the
practical impact of such guidelines, the results are often
disappointing. In the case of guidelines about diagnostic
procedures in drug allergy, site visits after a few years in
various clinics and institutions were rather chastening: the
recommended procedures were often not applied, even in the
institutions of some of the experts who had written them!
Hence my conviction that guidelines are only worth the effort
if some mechanism is established to control their application
and possibly enforce them.
Knowledge of history is a prerequisite for good
governance. May these historical notes on IAACI be of some
help to the future keepers of WAO.
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